ahpba 2018 finalprogram press 1 · ahpba 2018 annual meeting 47 wednesday, march 7, 2018 12:45pm -...
TRANSCRIPT
46 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
7:30am - 5:00pm
Ultrasound & Advanced Technology Course
Cowrie Foyer, Cowrie 1/2
7:30am - 8:00pm
Ultrasound & Advanced Technology Course Registration and Breakfast
8:00am - 9:20am
Welcome and Course Overview
Ellen J. Hagopian MD | Hackensack Meridian
US Principles & Instrumentation
Ellen J. Hagopian MD | Hackensack Meridian
US Scanning Techniques: TAUS, IOUS & LAP
Eren Berber MD | Cleveland Clinic Foundation
9:20am - 9:30am
Ultrasound Course Break
9:30am - 12:00pm
Liver US: Normal Anatomy and Pathologic Findings
Reid Adams MD | University of Virginia School of Medicine
Pancreatobiliary US: Normal Anatomy and Pathology
Nicholas Zyromski MD | Indiana University School of Medicine
Introduction to Hands On Sessions
Ellen Hagopian | Hackensack Meridian
10:50am – 11:00am
Ultrasound Course Break
HPB Anatomy and Techniques: TAUS
Thomas A. Aloia | The University of Texas, MD Anderson Cancer Center
Reid Adams MD | University of Virginia School of Medicine
Eren Berber MD | Cleveland Clinic Foundation
T. Clark Gamblin MD | Medical College of Wisconsin
Chet Hammill MD | Washington University
D. Rohan Jeyarajah MD | Trinity Care Surgical
Martin Palavecino MD | Hospital Italiano de Buenos Aires
Nicholas Zyromski MD | Indiana University School of Medicine
12:00pm - 12:45pm
Ultrasound & Advanced Technology Course Luncheon
WEDNESDAY, MARCH 7, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 46 2/22/18 9:13 PM
47AHPBA 2018 ANNUAL MEETING
WEDNESDAY, MARCH 7, 2018
12:45pm - 2:15pm
Techniques in Ultrasound Guidance: TAUS, IOUS & LAP
David Iannitti MD | Carolinas HealthCare System
Methods of Tumor Ablation in HPB Surgery
Robert CG Martin MD, PhD | University of Louisville
US Coding, Billing for the HPB Surgeon
D. Rohan Jeyarajah MD | Trinity Care Surgical
Getting Started
Ellen Hagopian | Hackensack Meridian
2:15pm - 2:30pm
Ultrasound Course Break
Cowrie Foyer
2:30pm - 5:00pm
Scanning Methods and Ultrasound Guidance: IOUS & LAP
Hands On Lab Using Inanimate and Phantom Models
Thomas A. Aloia MD | The University of Texas, MD Anderson Cancer Center
Reid Adams MD | University of Virginia School of Medicine
Eren Berber MD | Cleveland Clinic Foundation
T. Clark Gamblin MD | Medical College of Wisconsin
Chet Hammill MD | Washington University
W. Scott Helton MD | Virginia Mason Medical Center
David Iannitti MD | Carolinas HealthCare System
D. Rohan Jeyarajah MD | Trinity Care Surgical
Martin Palavecino MD | Hospital Italiano de Buenos Aires
Dennis Vrochides MD | Carolinas HealthCare System
Nicholas Zyromski MD | Indiana University School of Medicine
12:30pm - 1:30pm
Surgical Innovation Committee Meeting
Hospitality room 432
12:30pm - 1:30pm
Professional Development Committee Meeting
Periwinkle
1:30pm - 2:30pm
Clinical Trials Committee Meeting
Hospitality room 409
AG E N DA
AHPBA_2018_FinalProgram.indd 47 2/22/18 9:13 PM
48 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
1:30pm - 2:30pm
Conflict of Interest (COI) Committee Meeting
Hospitality room 432
1:30pm - 2:30pm
AHPBF Board Meeting
Periwinkle
2:30pm - 3:30pm
Finance Committee Meeting
Hospitality room 432
2:30pm - 3:30pm
Publications Committee Meeting
Periwinkle
3:00pm - 4:30pm
Education & Training Committee Meeting
Poinciana 3/4
3:30pm - 4:30pm
Program Committee Meeting
Poinciana 1/2
4:30pm - 6:30pm
HPB Program Directors Committee Meeting
Americana 3
4:30pm - 5:30pm
Research Committee Meeting
Poinciana 1/2
5:30pm - 6:30pm
Membership Committee Meeting
Poinciana 3/4
5:30pm - 6:30pm
International Relations Committee Meeting
Poinciana 1/2
WEDNESDAY, MARCH 7, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 48 2/22/18 9:13 PM
49AHPBA 2018 ANNUAL MEETING
6:00pm - 8:00pm
Registration Open
Rotunda East
6:00pm - 9:00pm
Ultrasound Course Fellows Practicum
Cowrie 1
6:30pm - 9:30pm
Executive Council Meeting
Poinciana 1/2
WEDNESDAY, MARCH 7, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 49 2/22/18 9:13 PM
50 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
6:00am - 9:00am
Ultrasound Course Fellows Practicum
Cowrie 1
7:00am - 6:30pm
Registration Open
Rotunda East
8:00am - 4:30pm
Pre Congress Symposium | HPB Across the Spectrum of Care
Americana 1/2
Moderator: Charles M. Vollmer MD | University of Pennsylvania
8:00am-10:15am
HPB Across the Spectrum of Care | Selecting the Right Patient
Moderators: Herbert J. Zeh MD | University of Pittsburgh Medical Center;
Javier C. Lendoire MD, PhD | Hospital Dr C Argerich
KEYNOTE SPEAKER: Prehab
Richard M. Charnley MD | Freeman Hospital
Bilobar Colorectal Mets: When to Operate?
Rene Adam MD | Paul Brousse Hospital
Cirrhosis and Surgery
Juan Francisco Guerra MD | Pontificia Universidad Católica de Chile
Role of Laparoscopy with HPB Cancers Today
Rebekah R. White MD | University of California San Diego
MIS or Open Whipple?
Horacio J. Asbun MD | Mayo Clinic
Salvage or Sucker: Transplanting the High MELD Patient
Julie K. Heimbach MD | Mayo Clinic
10:15am – 10:30am
Morning Beverage Break
Americana Foyer
THURSDAY, MARCH 8, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 50 2/22/18 9:13 PM
51AHPBA 2018 ANNUAL MEETING
10:30am-12:30pm
HPB Across the Spectrum of Care | Intraop Approaches for Success
Moderators: Carlos Chan MD | National Institute of Medical Sciences;
Sharon Weber, MD | University of Wisconsin
KEYNOTE SPEAKER: Coaching in the OR - Wait A Minute, Slow Down
Carol-anne Moulton MD | University Health Network, University of Toronto
Averting Biliary Leaks
Thomas Aloia MD | MD Anderson Cancer Center
Preventing Pancreatic Leaks
Charles M. Vollmer MD | University of Pennsylvania
Avoiding Blood Loss
Elijah Dixon MD | University of Calgary
Handing Over the Reigns
Paul D. Greig MD | University of Toronto
12:30pm – 1:30pm
Lunch Break (on own)
12:30pm - 1:30pm
AHPBA New Members Lunch with Leadership (by invite only)
Poinciana 3/4
1:30pm-4:30pm
HPB Across the Spectrum of Care | HPB Surgery: It’s Complicated
Moderators: Mariano Gimenez MD | University of Buenos Aires;
Mark P. Callery MD | Harvard Medical School
KEYNOTE SPEAKER: Classification of Complications and Benchmarking
Pierre-Alain Clavien MD PhD | University Hospital Zurich
Dealing with a Bile Duct Injury
Miguel Angel Mercado MD | Instituto Nacional de Ciencias Medicas
Y Nutricion Salvador Zubiran
Post-Op Hemorrhage
Major Lee MD PhD | Univeresity of Pennsylvania
Vascular Complications After a Liver Transplant
Satish N. Nadig MD, PhD | Medical University of South Carolina
Managing Pancreatic Leaks
Giuseppe Malleo MD, PhD | The Pancreas Institute, University of Verona
Dealing with Living Donor Death
Charles Miller MD | Cleveland Clinic
THURSDAY, MARCH 8, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 51 2/22/18 9:13 PM
52 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
3:00pm - 4:00pm
Ultrasound Subcommittee Meeting
Cowrie 2
4:30pm – 5:30pm
HPB Collaborative Meeting
Poinciana 1/2
5:30pm - 7:00pm
AHPBA Welcome Reception
Americana 4
5:30pm - 7:30pm
Bernard Langer Fellows Symposium
Americana 1/2
Moderators: M.B. Majella Doyle, MD, MBA | Washington University School of
Medicine; Blaire Anderson, MD | Washington University School of Medicine;
Robert Simon, MD | Cleveland Clinic Foundation
Honorary Welcome
Bernard Langer, MD | Toronto General Hospital
Best Practices for Securing a Job and Transitioning into Practice
Thomas Aloia MD | MD Anderson Cancer Center
How to Position Yourself for Leadership
Elijah Dixon MD | University of Calgary
Training in MIS HPB
Erin H. Baker MD | Carolinas Medical Center
How to Become a Surgical Scientist
Ryan C. Fields MD | Washington University School of Medicine
How to Assure Patients You are Capable
Sean P. Cleary MD | Mayo Clinic
Panelists: HPB Training – A Tripartite Perspective
Houssam G. Osman MD | Methodist Richardson Medical Center
Julie H. Hallet MD, MSc | Sunnybrook Health Sciences Centre,
University of Toronto
Kendra D. Conzen, MD | University of Colorado School of Medicine
9:30pm
Cocktails with AHPBA Leadership
Bar Collins
THURSDAY, MARCH 8, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 52 2/22/18 9:13 PM
53AHPBA 2018 ANNUAL MEETING
6:15am - 7:15am
AHPBF Fund Run
Check-in at Spa Front Desk
7:00am - 6:00pm
Registration Open
Rotunda East
7:00am - 8:00am
Continental Breakfast in Exhibit Hall
Americana 4
7:00am - 8:00am
Industry Sponsored Breakfast Symposium - Thank you Aesculap!
Poinciana 1/2
8:00am – 8:30am
Welcome & Opening Session
AHPBA President, Rebecca Minter MD | University of Wisconsin
8:30am - 9:30am
Presidential Plenary
Americana 1/2
Moderator: Rebecca Minter MD | University of Wisconsin
8:30am - 8:45am
1. MINIMALLY INVASIVE VERSUS OPEN DISTAL PANCREATECTOMY
(LEOPARD): MULTICENTER PATIENT-BLINDED RANDOMIZED
CONTROLLED TRIAL
Presenter: Thijs de Rooij MSc | Academic Medical Center
Invited Discussant: Elijah Dixon MD | University of Calgary
8:45am - 9:00am
2. REGIONAL DIFFERENCES IN GALLBLADDER CANCER
PATHOGENESIS: INSIGHTS FROM A COMPARISON OF TUMOR
MUTATIONS
Presenter: Raja Narayan MD, MPH | Memorial Sloan Kettering Cancer Center
Invited Discussant: Henry Pitt MD | Lewis Katz School of Medicine at Temple
University
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 53 2/22/18 9:13 PM
54 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
9:00am - 9:15am
3. EVALUATION OF HEPATOCELLULAR CARCINOMA CIRCULATING
TUMOR CELLS EXPRESSING PROGRAMMED DEATH-LIGAND 1
Presenter: Paul Winograd MD | David Geffen School of Medicine at UCLA
Invited Discussant: William Jarnagin MD | Memorial Sloan Kettering Cancer
Center
9:15am - 9:30am
4. SURGICAL COMPLICATIONS AFTER RIGHT HEPATECTOMY FOR LIVE
LIVER DONATION. A SINGLE CENTER EXPERIENCE AFTER >500 CASES
Presenter: Andre Gorgen MD | University Health Network, Toronto General
Hospital
Invited Discussant: Will Chapman MD | Washington University
9:30am - 10:30am
Presidential Address
Americana 1/2
Introduction: Charles M. Vollmer MD | University of Pennsylvania
Inclusivity and Diversity - the AHPBA’s Secret Sauce
Rebecca M. Minter MD | University of Wisconsin
10:30am - 11:00am
Morning Beverage Break, Exhibits & ePoster Viewing
Americana 4
11:00am - 12:30pm
AHPBA-SAGES Joint Symposium: Lap Liver Resections
Americana 1/2
Moderators: Nicholas A. O’Rourke MBBS | Royal Brisbane Hospital;
D. Rohan Jeyarajah MD | Methodist Richardson Medical Center
The State of MIS Liver Surgery
David Geller MD | University of Pittsburgh
Review of ILLS Paris Experience
Daniel Cherqui MD, PhD | Paul Brousse Hospital
Updates from EGMLLS 2017 Experience
Horacio J. Asbun MD | Mayo Clinic
MIS Training for Practicing HPB Surgeons and Fellows
Adnan Alseidi MD, EdM | Virginia Mason Medical Center
South American and Western Experience
Paulo Herman MD | University of São Paulo
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 54 2/22/18 9:13 PM
55AHPBA 2018 ANNUAL MEETING
11:00am - 12:30pm
Enhanced Recovery After HPB Surgery
Americana 3
Moderators: Sharon Weber MD | University of Wisconsin – Madison; Dionisios
Vrochides, MD, PhD | Carolinas Medical Center
Relationship Between Enhanced Recovery and Value Based Healthcare
Thomas Aloia MD | MD Anderson Cancer Center
Database Management and Compliance
Erin H. Baker MD | Carolinas Medical Center
Lessons Learned on the Way to a Liver Pathway
Alice C. Wei MD | University Health Network, University of Toronto
Predictive Analytics for Pancreas Pathway Development
Jason W. Denbo MD | University of Minnesota
Anesthesia Perspective: GDFT and Regional Blocks
Vijaya Gottumukkala MD | MD Anderson Cancer Center
11:00am - 12:30pm
Oral Presentations 1: Hepatobiliary
Poinciana 1/2
Moderators: Eddie Abdalla MD | Northside Hospital Cancer Institute; Cassio
Virgilio de Oliveira MD | Universidade Federal da Paraíba
11:00am - 11:12am
5. GROWTH SUPPRESSION BY ALTERATION IN KEAP1/NRF2-NOTCH-
STAT3 SIGNALING IN CHOLANGIOCARCINOMA
Presenter: Muthusamy Kunnimalaiyaan PhD | Medical College of Wisconsin
Invited Discussant: Steve Hughes MD | University of Florida
11:12am - 11:24am
6. LONG-TERM OUTCOMES OF PATIENTS WITH INTRADUCTAL
GROWTH SUB-TYPE OF INTRAHEPATIC CHOLANGIOCARCINOMA
Presenter: Fabio Bagante MD | The Ohio State University
Invited Discussant: Fabio Luiz Waechter MD, PhD | Universidade Federal De
Ciências Da Saúde De Porto Alegre
11:24am - 11:36am
7. DOES ADDITIONAL RE-RESECTION OF A POSITIVE PROXIMAL
MARGIN IN HILAR CHOLANGIOCARCINOMA AFFECT SURVIVAL?
MAYO EXPERIENCE
Presenter: Lavanya Yohanathan MD | Mayo Clinic
Invited Discussant: Mike D’Angelica MD | Memorial Sloan Kettering Cancer
Center
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 55 2/22/18 9:13 PM
56 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
11:36am - 11:48am
8. IS HEPATECTOMY SAFE FOLLOWING YTTRIUM-90 THERAPY?
A MULTI-INSTITUTIONAL INTERNATIONAL EXPERIENCE
Presenter: Laleh Melstrom MD, MS | City of Hope Cancer Center
Invited Discussant: Parsia Vagefi MD | University of Texas, Southwestern
11:48am - 12:00pm
9. LAPAROSCOPIC PARENCHYMA-SPARING LIVER RESECTION FOR
COLORECTAL METASTASES
Presenter: Davit Aghayan MD | Oslo University Hospital Invited Discussant:
Ching-Wei Tzeng MD | University of Texas, MD Anderson Cancer Center
12:00pm - 12:12pm
10. CHEMORADIOTHERAPY FOR POSITIVE HEPATIC MARGIN ON
CHOLANGIOCARCINOMA
Presenter: Teiichi Sugiura MD | Shizuoka Cancer Center Invited Discussant:
Chandrakanth Are MBBS, MBA | University of Nebraska Medical Center
12:12pm - 12:24pm
11. SURVIVAL AFTER RESECTION OF MULTIPLE TUMOR FOCI OF
INTRAHEPATIC CHOLANGIOCARCINOMA
Presenter: Stefan Buettner BSc | The Ohio State University Invited
Discussant: Kimberly Bertens MD, MPH | The Ottawa Hospital
11:00am - 12:30pm
Oral Presentations 2: Pancreas
Poinciana 3/4
Moderators: Michael Kendrick MD | Mayo Clinic Rochester; Rebecca Snyder MD,
MPH | University of South Carolina School of Medicine- Greenville
11:00am - 11:12am
12. THE CONUNDRUM OF <2 CM PANCREATIC NEUROENDOCRINE
TUMORS: A PREOPERATIVE RISK SCORE TO PREDICT LYMPH NODE
METASTASES AND GUIDE SURGICAL MANAGEMENT
Presenter: Alexandra Lopez-Aguiar MD | Emory University
Invited Discussant: Yumon Fong MD | City of Hope
11:12am - 11:24am
13. EVALUATION OF THE SAFETY AND EFFICACY OF STING AGONISTS
FOR DOWNSTAGING AND MARGIN ACCENTUATION STRATEGIES IN A
MURINE MODEL OF LOCALLY ADVANCED PANCREATIC CANCER
Presenter: Ephraim Tang MD, MSc | Providence Cancer Center
Invited Discussant: Rebecca Snyder MD, MPH | University of South Carolina
School of Medicine-Greenville
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 56 2/22/18 9:13 PM
57AHPBA 2018 ANNUAL MEETING
11:24am - 11:36am
14. MONITORING GASTRIC MYOELECTRIC AFTER
PANCREATICODUODENECTOMY FOR DIET “READINESS”
Presenter: Brendan Visser MD | Stanford University
Invited Discussant: Jin He MD, PhD | Johns Hopkins University School of
Medicine
11:36am - 11:48am
15. DECODING GRADE B PANCREATIC FISTULA: A CLINICAL AND
ECONOMICAL ANALYSIS AND SUB-CLASSIFICATION PROPOSAL
Presenter: Giuseppe Malleo MD | University of Pennsylvania
Invited Discussant: Kamran Idrees MD, MSCI, MMHC | Vanderbilt University
Medical Center
11:48am - 12:00pm
16. ENHANCEMENT OF ANTI-TUMOR IMMUNITY AND SURVIVAL
PROLONGATION BY NEOADJUVANT FOLINIC ACID 5-FU, OXALIPLATIN
AND IRINOTECAN (FOLFIRINOX) IN PANCREATIC DUCTAL
ADENOCARCINOMA PATIENTS
Presenter: Lei Cai MD, PhD | Massachusetts General Hospital, Harvard
Medical School
Invited Discussant: George Poultsides MD | Stanford University
12:00pm - 12:12pm
17. QUALITY IMPROVEMENT FOR PANCREATODUODENECTOMY
THROUGH THE DEVELOPMENT AND INTEGRATION OF PROCEDURE-
SPECIFIC RISK ASSESSMENT
Presenter: Brett Ecker MD | University of Pennsylvania
Invited Discussant: Stephen Behrman MD | University of Tennessee Health
Science Center
12:12pm - 12:24pm
18. RADIOLOGICAL FACTORS ASSOCIATED WITH MISSTAGING OF
PANCREATIC DUCTAL ADENOCARCINOMA
Presenter: Ammar Javed MD | Johns Hopkins University School of Medicine
Invited Discussant: Courtney Scaife MD | Huntsman Cancer Institute,
University of Utah
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 57 2/22/18 9:13 PM
58 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
11:00am - 12:30pm
Oral Presentations 3: Transplant
Cowrie 1/2
Moderators: Anand Annamalai MD | St.Vincents Medical Center; Steven Hanish
MD | University of Maryland
11:00am - 11:12am
19. RISK OF TRANSPLANT WAITLIST PROGRESSION IN
HEPATOCELLULAR CARCINOMA USING BIOMARKERS OF
TUMOR IMMUNE TOLERANCE PRIOR TO TRANSARTERIAL
CHEMOEMBOLIZATION
Presenter: Paul Thevenot PhD | Ochsner Health System
Invited Discussant: Stephen Gray MD | University of Alabama at Birmingham
11:12am - 11:24am
20. HALTHCC AS A NOVEL TUMOR RESPONSE METRIC IN PATIENTS
WITH HEPATOCELLULAR CARCINOMA UNDERGOING LOCOREGIONAL
THERAPY WHILE AWAITING LIVER TRANSPLANTATION
Presenter: Kazunari Sasaki MD | Cleveland Clinic Foundation
Invited Discussant: Karim Halazun MD | Weill Cornell Medicine
11:24am - 11:36am
21. OUTCOMES OF TRANSPLANTATION FOR BIPHENOTYPIC LIVER
TUMORS ARE SIMILAR TO OUTCOMES OF TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA
Presenter: Leigh Anne Dageforde MD, MPH | Washington University
Invited Discussant: Vijay Vij MBBS,MS, MRCS | Fortis Hospitals
11:36am - 11:48am
22. IMPACT OF SIDE-TO-SIDE CAVOCAVOSTOMY VERSUS
TRADITIONAL PIGGYBACK IMPLANTATION IN LIVER TRANSPLANT
Presenter: Vikrom Dhar MD | University of Cincinnati
Invited Discussant: John Renz MD, PhD | University of Chicago
11:48am - 12:00pm
23. REDUCING READMISSIONS AFTER LIVER TRANSPLANTATION
Presenter: David Levi MD | Carolinas HealthCare System
Invited Discussant: Chris Sonnenday MD, MHS | University of Michigan
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 58 2/22/18 9:13 PM
59AHPBA 2018 ANNUAL MEETING
12:00pm - 12:12pm
24. UNDERSTANDING FIBRINOLYSIS SHUTDOWN IN LIVER
TRANSPLANTATION
Presenter: Vikrom Dhar MD | University of Cincinnati
Invited Discussant: Kristopher Croome MD | Mayo Clinic Florida
12:12pm - 12:24pm
25. EFFECTS OF SEVOFLURANE METABOLITE HEXAFLUORO-2-
PROPANOL PRECONDITIONING IN EXPERIMENTAL LIVER ISCHEMIA
REPERFUSION INJURY
Presenter: Joel Rocha Filho MD, PhD | Hospital das Clinicas of University
of Sao Paulo
Invited Discussant: Charles Rosen MD | Mayo Clinic
12:00pm – 1:00pm
Industry Lunch Symposium - Thank you Medtronic!
Poinciana 3/4
12:30pm - 1:00pm
Lunch in Exhibit Hall
Americana 4
12:30pm - 1:30pm
Advance Practice Provider Committee Meeting
Cowrie 2
1:00pm - 2:30pm
Vascular Resections in HPB Cancer - When, Where, How?
Americana 1/2
Moderators: Carlos U. Corvera MD | UCSF; Oscar C. Imventarza MD | Hospital
Argerich- Hospital Garrahan
Extended Resections in Pancreatic Cancer
Jeffrey E. Lee MD | UTMD Anderson Cancer Center
IVC Resection with Hepatectomy
Gabriel E. Gondolesi MD | Fundacion Favaloro
Aggressive HCC Resections with Portal Vein Thrombosis
Jean C. Emond MD | Columbia Univeristy and The New York Presbyterian
Hospital
Hilar Cholangiocarcinoma with Vascular Resections
Christopher J. Sonnenday MD, MHS | University of Michigan
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 59 2/22/18 9:13 PM
60 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
1:00pm - 2:30pm
Does the Evidence Truly Support Aggressive Surgical or Medical Treatment in
HPB Surgery?
Americana 3
Moderators: Jeffrey B. Matthews MD | University of Chicago;
Jose P. Garbanzo MD | Centro de Enfermedades del Higado
Pancreatic Adenocarcinoma
Steven Gallinger MD | University Health Network, University of Toronto
PNETs
Emily R. Winslow MD, MS | University of Wisconsin
Hilar Cholangiocarcinoma
William R. Jarnagin MD | Memorial Sloan Kettering Cancer Center
HCC
Sean P. Cleary MD | Mayo Clinic
Incidental Gall Bladder Cancer: Radical Resection?
Jean M. Butte MD | Instituto Oncologico Fundacion Arturo Lopez Perez
1:00pm - 2:30pm
Mini Oral Sessions | Monitor 1 Pancreas Cancer
Americana Foyer
Moderator: Kevin Billingsley MD | Oregon Health and Science University
1:00pm - 1:05pm
MO 1. OPERATIVE MANAGEMENT OF LOCALLY ADVANCED
PANCREATIC CANCER: ANALYSIS OF THE NATIONAL CANCER
DATABASE
Presenter: Chad Barnes MD | Medical College of Wisconsin
1:05pm - 1:10pm
MO 2. ALL TALK AND NO ACTION: A REVIEW OF THE USE OF
NEOADJUVANT CHEMOTHERAPY FOR PANCREATIC CANCER IN THE
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM
Presenter: Erin Gilbert MD | Oregon Health and Sciences University
1:10pm - 1:15pm
MO 3. BILIARY MICROBIOME IN PANCREATIC CANCER: ALTERATIONS
WITH NEOADJUVANT THERAPY
Presenter: Neha Goel MD | Fox Chase Cancer Center
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 60 2/22/18 9:13 PM
61AHPBA 2018 ANNUAL MEETING
1:15pm - 1:20pm
MO 4. EXPLORATION OF IRREVERSIBLE ELECTROPORATION INDUCED
APOPTOTIC PATHWAYS AND MECHANISMS IN PANCREATIC
ADENOCARCINOMA CELLS
Presenter: Christopher McNicoll MD, MPH, MS | University of Las Vegas
Nevada School of Medicine
1:20pm - 1:25pm
MO 5. PREDICTORS OF RECURRENCE IN PATIENTS WITH SOLID
PSEUDOPAPILLARY NEOPLASMS OF THE PANCREAS: A SYSTEMATIC
REVIEW AND META-ANALYSIS OF 2579 PATIENTS
Presenter: NATESH YEPURI MBBS | Suny Upstate Medical University
1:25pm - 1:30pm
MO 6. HIGH VOLUME PANCREATICODUODENECTOMY PERFORMED
AT A COMMUNITY CANCER CENTER
Presenter: Arvind Sabesan MD | Helen F Graham Cancer Center & Research
Institute
1:30pm - 1:35pm
MO 7. IMPROVED OVERALL SURVIVAL IN PATIENTS WITH LOCALLY
ADVANCED PANCREATIC CANCER UNDERGOING NEOADJUVANT
THERAPY AND IRREVERSIBLE ELECTROPORATION
Presenter: M. Farzan Rashid BS | Columbia University
1:35pm - 1:40pm
MO 8. RECURRENT OR METACHRONOUS ADENOCARCINOMA OF THE
PANCREATIC REMNANT: LONG-TERM SURVIVAL AFTER COMPLETION
PANCREATECTOMY
Presenter: Thuy Tran MD | Stanford University
1:40pm - 1:45pm
MO 9. THE ROLE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE
RATIO IN PREDICTING SURVIVAL IN PANCREATIC CANCER PATIENTS
BASED ON NEOADJUVANT CHEMOTHERAPY PATHOLOGICAL
RESPONSE.
Presenter: Basem Azab MD | University of Miami Miller School of Medicine
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 61 2/22/18 9:13 PM
62 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
1:45pm - 1:50pm
MO 10. EVALUATING A SINGLE NEEDLE HIGH-FREQUENCY
IRREVERSIBLE ELECTROPORATION (H-FIRE) PROBE FOR PANCREATIC
ABLATION IN VIVO.
Presenter: Iain McKillop PhD | Carolinas HealthCare System
1:50pm - 1:55pm
MO 11. A MULTI-INSTITUTIONAL ANALYSIS OF FACTORS AFFECTING
SURVIVAL FOR LEFT-SIDED PANCREATIC ADENOCARCINOMA
Presenter: Farzad Alemi MD | Virginia Mason Medical Center
1:55pm - 2:00pm
MO 12. IMPACT OF TUMOR LOCATION ON RESECTABILITY AND
SURVIVAL FOR PANCREATIC DUCTAL ADENOCARCINOMA
Presenter: Vikrom Dhar MD | University of Cincinnati
2:00pm - 2:05pm
MO 13. THE CLINICAL IMPACT OF LEFT GASTRIC ARTERY
RECONSTRUCTION/PRESERVATION DURING DISTAL
PANCREATECTOMY WITH CELIAC AXIS RESECTION FOR PANCREATIC
BODY CANCER
Presenter: Atsushi Oba MD, PhD | Cancer Institute Hospital, Japanese
Foundation for Cancer Research
2:05pm - 2:10pm
MO 14. CHEMOTHERAPY VS CHEMORADIATION AS
PREOPERATIVE THERAPY FOR RESECTABLE PANCREATIC DUCTAL
ADENOCARCINOMA: A PROPENSITY SCORE ADJUSTED ANALYSIS
Presenter: Jordan Cloyd MD | The University of Texas MD Anderson Cancer
Center
2:10pm - 2:15pm
MO 15. DOES NEOADJUVANT THERAPY AFFECT PERIOPERATIVE
OUTCOMES IN SARCOPENIC PATIENTS WITH PANCREATIC
ADENOCARCINOMA?
Presenter: Dylan Kahler BA | University of Pittsburgh Medical Center
2:15pm - 2:20pm
MO 16. PREDICTING RE-ADMISSION IN SUBTOTAL PANCREATECTOMY
PATIENTS
Presenter: Michelle Huyser MD | Kaiser Permanente, Oakland Medical
Center
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 62 2/22/18 9:13 PM
63AHPBA 2018 ANNUAL MEETING
2:20pm - 2:25pm
MO 17. PANCREATICODUODENECTOMY AND VEIN RESECTION
WITHOUT RECONSTRUCTION FOR LOCALLY ADVANCED PANCREATIC
CANCER: A CASE SERIES
Presenter: Bradley Reames MD, MS | Johns Hopkins University School of
Medicine
2:25pm - 2:30pm
MO 18. IMPACT OF PERIOPERATIVE BLOOD TRANSFUSIONS ON
SURVIVAL IN PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC
ADENOCARCINOMA AFTER NEOADJUVANT THERAPY
Presenter: Rebecca Snyder MD, MPH | The University of Texas MD Anderson
Cancer Center
1:00pm - 2:30pm
Mini Oral Sessions | Monitor 2 Pancreas
Americana Foyer
Moderator: Attila Nakeeb MD | Indiana University
1:00pm - 1:05pm
MO 19. INTERNATIONAL VALIDATION OF THE UPDATED
INTERNATIONAL STUDY GROUP OF PANCREATIC SURGERY
DEFINITION OF POSTOPERATIVE PANCREATIC FISTULA AFTER DISTAL
PANCREATECTOMY
Presenter: Jony van Hilst MD | Academic Medical Center
1:05pm - 1:10pm
MO 20. PANCREATIC AND BILIARY LEAKS IN FRAIL. SAME INCIDENCE,
GRAVE IMPACT
Presenter: Ioannis Konstantinidis MD | City of Hope Cancer Center
1:10pm - 1:15pm
MO 21. LONG TERM EXOCRINE AND ENDOCRINE FUNCTION AFTER
PANCREATECTOMY
Presenter: Blaire Anderson MD | Washington University
1:15pm - 1:20pm
MO 22. THE TRUE COST OF HIGH VOLUME WHIPPLE PROCEDURES
Presenter: Michael Lopez DO | University of Miami- Palm Beach
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 63 2/22/18 9:13 PM
64 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
1:20pm - 1:25pm
MO 23. DISTAL SPLENORENAL AND MESOCAVAL SHUNTING AT THE
TIME OF PANCREATECTOMY: AN IMPORTANT ADJUNCT TO THE
OPERATIVE MANAGEMENT OF SELECTED PATIENTS.
Presenter: Mariana Chavez MD | Medical College of Wisconsin
1:25pm - 1:30pm
MO 24. PREOPERATIVE CYTOKINE EXPRESSION IS ASSOCIATED WITH
PERIOPERATIVE OUTCOMES AFTER PANCREATECTOMY
Presenter: Malcolm Hart Squires MD | The Ohio State University
1:30pm - 1:35pm
MO 25. DEFINING THE PRACTICE OF DISTAL PANCREATECTOMY
AROUND THE WORLD
Presenter: Giuseppe Malleo MD | University of Pennsylvania
1:35pm - 1:40pm
MO 26. TRENDS AND SEASONALITY IN BILIARY AND ALCOHOLIC
ACUTE PANCREATITIS INCIDENCE IN THE UNITED STATES
Presenter: Steven Clark Cunningham MD | Saint Agnes Hospital Center
1:40pm - 1:45pm
MO 27. TRANSMEMBRANE MUCIN MUC13 DISTINGUISHES
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS FROM NON-
MUCINOUS CYSTS AND IS ASSOCIATED WITH HIGH-RISK LESIONS
Presenter: Zachary Stiles DO | University of Tennessee Health Science
Center
1:45pm - 1:50pm
MO 28. WEEKEND EFFECT IS ASSOCIATED WITH ADVERSE OUTCOMES
IN POSTOPERATIVE READMISSIONS FOLLOWING PANCREATIC
RESECTION
Presenter: Anai Kothari MD, MS | Loyola University Medical Center
1:50pm - 1:55pm
MO 29. BILIARY ANASTOMOTIC STRICTURES AFTER
PANCREATICODUODENECTOMY: AN UNDERAPPRECIATED
COMPLICATION
Presenter: Ammar Javed MD | Johns Hopkins University School of Medicine
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 64 2/22/18 9:13 PM
65AHPBA 2018 ANNUAL MEETING
1:55pm - 2:00pm
MO 30. COMPLICATIONS FROM RADICAL ANTEGRADE MODULAR
PANCREATICOSPLENECTOMY MAY BE UNDER-REPORTED IN ACS-
NSQIP
Presenter: Tarin Worrest MD | Oregon Health and Sciences University
2:00pm - 2:05pm
MO 31. ANALYSIS OF 90-DAY READMISSION RATES AND HEALTHCARE
COST IN PANCREATIC SURGERY: WHAT IF BUNDLED PAYMENT
SYSTEMS WERE APPLIED TO PANCREATIC SURGERY?
Presenter: Michael LeCompte MD | Vanderbilt University Medical Center
2:05pm - 2:10pm
MO 32. EVALUATING THE ACS-NSQIP RISK CALCULATOR IN PRIMARY
PANCREATIC NEUROENDOCRINE TUMOR: RESULTS FROM THE UNITED
STATES NEUROENDOCRINE TUMOR STUDY GROUP
Presenter: Eliza Beal MD | The Ohio State University Wexner Medical Center
and James Comprehensive Cancer Center
2:10pm - 2:15pm
MO 33. PRESENCE OF ADDICTION DOES NOT PREDICT
WORSE OUTCOMES WITH RESPECT TO PAIN AFTER TOTAL
PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION
Presenter: Robert Simon MD | Cleveland Clinic Foundation
2:15pm - 2:20pm
MO 34. THE BENEFICIAL EFFECTS OF MINIMIZING BLOOD LOSS IN
PANCREATODUODENECTOMY
Presenter: Thomas Seykora BA | University of Pennsylvania
2:20pm - 2:25pm
MO 35. AN ANALYSIS OF 6,125 PANCREATICOJEJUNAL
ANASTOMOSES: DOES TECHNIQUE MATTER?
Presenter: Lyonell Kone MD, MHS | University of Illinois at Chicago
2:25pm - 2:30pm
MO 36. MACHINE LEARNING AND PREDICTIVE ANALYTICS PROVIDE
INDIVIDUALIZED RISK PROFILES FOR PATIENTS UNDERGOING
MINIMALLY INVASIVE LEFT PANCREATECTOMY
Presenter: Michael Passeri MD | Carolinas HealthCare System
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 65 2/22/18 9:13 PM
66 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
1:00pm - 2:30pm
Mini Oral Sessions | Monitor 3 Liver
Americana Foyer
Moderator: David Iannitti MD | Carolinas HealthCare System
1:00pm - 1:05pm
MO 37. WHO NEEDS A DRAIN AFTER MAJOR HEPATECTOMY?
Presenter: Konstantinos Zorbas MD | Lewis Katz School of Medicine at
Temple University Hospital
1:05pm - 1:10pm
MO 38. CTLA-4 BLOCKADE INDUCES INDOLEAMINE
2,3-DIOXYGENASE WHERE TREATMENT WITH 1-METHYL-D-
TRYPTOPHAN DISPLAYS GREATER TREATMENT EFFECT IN TUMORS
WITH HIGH IDO EXPRESSION.
Presenter: Zachary Brown DO | National Institutes of Health
1:10pm - 1:15pm
MO 39. INCREMENTAL COSTS AND OUTCOMES OF HEPATECTOMY
WITH VS WITHOUT RESECTION FOR METASTATIC CANCER
Presenter: Jay Idrees MD | The Ohio State University
1:15pm - 1:20pm
MO 40. SUPERUSERS OF POSTOPERATIVE HEPATOBILIARY CARE:
IDENTIFYING DRIVERS OF EXTREME HEALTHCARE COSTS USING THE
NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM
Presenter: Sarah Brownlee BA | Loyola University Medical Center
1:20pm - 1:25pm
MO 41. DOES METABOLIC SYNDROME AFFECT THE SHORT- AND
LONG-TERM OUTCOMES OF PATIENTS UNDERGOING HEPATIC
RESECTION? ANALYSIS OF A SINGLE TERTIARY CENTER DATABASE
Presenter: Mohammed Al-Temimi MD, MPH | Kaiser Permanente, Los
Angeles Medical Center
1:25pm - 1:30pm
MO 42. QUANTITATIVE CT IMAGING FEATURES CORRELATE WITH
COLORECTAL CANCER LIVER METASTASES (CLM) MUTATIONAL
STATUS
Presenter: Rebecca Marcus MD | The University of Texas MD Anderson
Cancer Center
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 66 2/22/18 9:13 PM
67AHPBA 2018 ANNUAL MEETING
1:30pm - 1:35pm
MO 43. PRINGLE MANEUVER DURING LIVER RESECTIONS IN THE
UNITED STATES: PATTERNS OF USE AND IMPACT IN OUTCOMES
Presenter: Ali Mokdad MD, MS | University of Texas Southwestern
1:35pm - 1:40pm
MO 44. QUANTINTATIVE RISK ASSESSMENT FOR POST-
HEPATECTOMY LIVER FAILURE: ANALYSIS OF THE 2015 ACS-NSQIP
PROCEDURE-TARGETED HEPATECTOMY DATABASE
Presenter: Yana Puckett MD | Texas Tech University Health Sciences Center
1:40pm - 1:45pm
MO 45. THE LIVER HANGING MANEUVER REVISITED: A CADERVERIC
STUDY OF THE WIDTH OF THE RETRO-HEPATIC AVASCULAR SPACE
Presenter: Atsushi Shimizu MD, PhD | Jichi Medical University
1:45pm - 1:50pm
MO 46. THE USE OF INDOCYANINE GREEN FLUORESCENCE FOR
INTRAOPERATIVE VISUALIZATION OF LIVER TUMORS
Presenter: Eren Berber MD | Cleveland Clinic Foundation
1:50pm - 1:55pm
MO 47. KRAS MUTATIONAL STATUS SURPASSES THE TREATMENT
MODALITY IN PATIENTS WITH COLORECTAL LIVER METASTASES
Presenter: Hideo Takahashi MD | Cleveland Clinic Foundation
1:55pm - 2:00pm
MO 48. LONG TERM ONCOLOGIC OUTCOMES OF ROBOTIC LIVER
RESECTION FOR PRIMARY LIVER CANCERS
Presenter: Sidrah Khan MD | University of Pittsburgh Medical Center
2:00pm - 2:05pm
MO 49. YOUNGER PATIENTS WITH RESECTABLE COLORECTAL LIVER
METASTASES HAVE COMPARABLE SURVIVAL TO OLDER PATIENTS
DESPITE WORSE HISTOPATHOLOGIC FEATURES AND INCREASED RAS
MUTATIONS
Presenter: Claire Goumard MD | The University of Texas MD Anderson
Cancer Center
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 67 2/22/18 9:13 PM
68 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
2:05pm - 2:10pm
MO 50. BENEFITS OF HAND-ASSISTED LAPAROSCOPIC HEPATECTOMY
Presenter: Luis Mercado MD | Hospital Universitario Fundación Favaloro
2:10pm - 2:15pm
MO 51. UNIQUE TECHNICAL COMPLEXITIES AND EFFICACY OF ERCP
AFTER IRREVERSIBLE ELECTROPORATION FOR LOCALLY ADVANCED
PANCREATIC CANCER
Presenter: Neal Bhutiani MD | University of Louisville School of Medicine
2:15pm - 2:20pm
MO 53. PROGNOSTIC SIGNIFICANCE OF PRIMARY TUMOR SIDEDNESS
IN PATIENTS UNDERGOING LIVER RESECTION FOR METASTATIC
COLORECTAL CANCER
Presenter: Jenny Lim MD, MHSc | Duke University Medical Center
2:20pm - 2:25pm
MO 54. TUMOR GRADE SHOULD INFLUENCE THE UTILIZATION OF
PORTAL LYMPHADENECTOMY FOR EARLY STAGE INTRAHEPATIC
CHOLANGIOCARCINOMA
Presenter: Sean Martin DO | National Institutes of Health
1:00pm - 2:45pm
Mini Oral Sessions | Monitor 4 GB/Cholangiocarcinoma/PNET
Americana Foyer
Moderator: T. Clark Gamblin MD, MS, MBA | Medical College of Wisconsin
1:00pm - 1:05pm
MO 55. STAGING GALLBLADDER CANCER WITH LYMPHADENECTOMY:
THE PRACTICAL APPLICATION OF 6 LYMPH NODES
Presenter: Natasha Leigh MD | Icahn School of Medicine at Mount Sinai
1:05pm - 1:10pm
MO 56. IMPROVING OUTCOMES OF CHOLANGIOCARCINOMA: AN
ANALYSIS OF THE SEER DATABASE
Presenter: Aitua Salami MD, MPH | Einstein Healthcare Network
1:10pm - 1:15pm
MO 57. REVISION OF NATIONWIDE PRACTICE PATTERNS IN THE
MANAGEMENT OF T2 GALLBLADDER CARCINOMA
Presenter: Francisco Igor Macedo MD | University of Miami Miller School of
Medicine
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 68 2/22/18 9:13 PM
69AHPBA 2018 ANNUAL MEETING
1:15pm - 1:20pm
MO 58. PREOPERATIVE BILIARY STENTING IS ASSOCIATED WITH
INCREASED COMPLICATIONS AFTER LIVER RESECTION FOR
CHOLANGIOCARCINOMA
Presenter: Rajesh Ramanathan MD | University of Pittsburgh Medical Center
1:20pm - 1:25pm
MO 59. SURGERY MAY NOT IMPROVE SURVIVAL FOR LYMPH NODE
POSITIVE INTRAHEPATIC CHOLANGIOCARCINOMA COMPARED TO
CHEMOTHERAPY ALONE
Presenter: Scott Kizy MD | University of Minnesota
1:25pm - 1:30pm
MO 60. R1 RESECTION IN HILAR CHOLANGIOCARCINOMA MIGHT NOT
TRANSLATE TO INFERIOR PATIENT SURVIVAL; AN INTENTION TO
TREAT ANALYSIS
Presenter: Michael Passeri MD | Carolinas HealthCare System
1:30pm - 1:35pm
MO 61. NEOADJUVANT SYSTEMIC THERAPY FOR
CHOLANGIOCARCINOMA : A NSQIP DATABASE ANALYSIS
Presenter: Dominic Sanford MD | Mayo Clinic, Florida
1:35pm - 1:40pm
MO 62. MAJOR COMPLICATIONS FOLLOWING PANCREATECTOMY FOR
SMALL PANCREATIC NEUROENDOCRINE AND CYSTIC NEOPLASMS
LESS THAN 2-CM: AN ARGUMENT FOR SELECTIVE OBSERVATION OR
RESECTION
Presenter: Thuy Tran MD | University of Illinois at Chicago
1:40pm - 1:45pm
MO 63. SAFETY AND EFFICACY OF IRREVERSIBLE ELECTROPORATION
IN THE TREATMENT OF OBSTRUCTIVE JAUNDICE IN LOCALLY
ADVANCED HILAR CHOLANGIOCARCINOMA
Presenter: Emily Martin MEng | University of Louisville School of Medicine
1:45pm - 1:50pm
MO 64. EFFECT OF BLOOD TRANSFUSION ON SURVIVAL FOR
RESECTED PANCREATIC NEUROENDOCRINE TUMORS: ANALYSIS OF
THE U.S. NEUROENDOCRINE STUDY GROUP
Presenter: Paula Marincola Smith MD | Vanderbilt University Medical Center
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 69 2/22/18 9:13 PM
70 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
1:50pm - 1:55pm
MO 65. ONCOLOGIC OUTCOMES OF PREOPERATIVE THERAPY FOR
DISTAL CHOLANGIOCARCINOMA
Presenter: Jordan Cloyd MD | The University of Texas MD Anderson Cancer
Center
1:55pm - 2:00pm
MO 66. ROLE OF SURGICAL TREATMENT FOR HEPATOLITHIASIS-
ASSOCIATED INTRAHEPATIC CHOLANGIOCARCINOMA: A
RETROSPECTIVE STUDY IN A SINGLE INSTITUTION
Presenter: Weidong Xiao MD, PhD | The First Affiliated Hospital of Nanchang
University
2:00pm - 2:05pm
MO 67. IS PRIMARY SCLEROSING CHOLANGITIS-RELATED
GALLBLADDER CANCER ASSOCIATED WITH WORSE SURVIVAL?
RESULTS FROM THE U.S. EXTRAHEPATIC BILIARY MALIGNANCY
CONSORTIUM
Presenter: Victoria Rendell MD | University of Wisconsin School of Medicine
and Public Health
2:05pm - 2:10pm
MO 68. INCIDENCE OF GALLBLADDER CANCER AND OVERALL
SURVIVAL IN DIFFERENT RACIAL POPULATIONS IN NORTHERN
CALIFORNIA
Presenter: Michelle Huyser MD | Kaiser Permanente, Oakland Medical
Center
2:10pm - 2:15pm
MO 69. IS CYTOREDUCTIVE SURGERY AND HYPERTHERMIC
INTRAPERITONEAL CHEMOTHERAPY INDICATED IN HEPATOBILIARY
MALIGNANCIES?
Presenter: Natasha Leigh MD | Icahn School of Medicine at Mount Sinai
2:15pm - 2:20pm
MO 70. A LITERATURE-BASED TREATMENT ALGORITHM FOR LOW-
GRADE NEUROENDOCRINE LIVER METASTASES
Presenter: Neal Bhutiani MD | University of Louisville School of Medicine
2:20pm - 2:25pm
MO 71. RE-RESECTION IN INCIDENTAL GALLBLADDER CANCER: LYMPH
NODES RETRIEVED IN OPEN VS LAPAROSCOPIC APPROACH
Presenter: Oscar Guevara MD, MSc | Universidad Nacional de Colombia
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 70 2/22/18 9:13 PM
71AHPBA 2018 ANNUAL MEETING
2:25pm - 2:30pm
MO 72. THE INTERSECTION OF SURGERY AND BIOENGINEERING:
INNOVATIVE SOLUTIONS FOR CLINICAL PROBLEMS IN PANCREATIC
AND OTHER CANCERS.
Presenter: Matthew Ware PhD | Baylor College of Medicine
2:30pm - 2:35pm
MO 73. REPEAT CHOLECYSTECTOMY FOR THE RETAINED
GALLBLADDER REMNANT: PRESENTATION AND MANAGEMENT
Presenter: Seth Concors MD | University of Pennsylvania
2:35pm - 2:40pm
MO 74. PROGNOSTIC VALUE OF HEPATOCELLULAR CARCINOMA
STAGING SYSTEMS: A COMPARISON
Presenter: Shelby Bergstresser BS | University of Alabama at Birmingham
School of Medicine
2:40pm - 2:45pm
MO 75. MELD SCORE IS AN INDEPENDENT PREDICTOR OF MORTALITY
IN PATIENTS WITH NORMAL LIVER PARENCHYMA AFTER LIVER
RESECTION
Presenter: Victor Zaydfudim MD, MPH | University of Virginia
1:30pm - 2:30pm
Latin American Presidents Committee Meeting
Cowrie 2
2:30pm - 3:30pm
Clinical Trials in Progress: Barriers to Prospective Trials in HPB Surgery
Americana 1/2
Moderators: Daniel E. Abbott MD | University of Wisconsin;
Natalie Coburn MD, MPH | The Odette Cancer Centre
Collaborative Multicenter Trials in HBP Surgery
Michael D’Angelica MD | Memorial Sloan Kettering Cancer Center
Oslo COMET Randomized Trial: Lessons Learned
Asmund A. Fretland MD | Oslo University Hospital
Single Center Prospective Trials: Are They Worth It?
Peter J. Allen MD | Memorial Sloan Kettering Cancer Center
Where Should the Funding Come From and How to Get It?
Charles A. Staley MD | Emory University
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 71 2/22/18 9:13 PM
72 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
2:30pm - 3:30pm
State of the Art Lecture | Of Math and Medicine
Americana 3
Moderator: Hari Nathan, MD, PhD | University of Michigan
Advancing Surgical Policy and Practice Through Big Data
Dorry Segev MD PhD | Johns Hopkins University
2:30pm - 3:30pm
Basic Translational Science
Poinciana 1/2
Moderators: Ryan C. Fields MD | Washington University School of Medicine;
Vikas Dudeja MD | University of Miami
Personalized Medicine in Biliary Tract Cancers
Jason K. Sicklick MD | University of California, San Diego Moores Cancer Center
Role of CMV in Allograft Chronic Rejection
Susan L. Orloff MD | Oregon Health & Science University
Hypothermic Ex Vivo Liver Perfusion
James V. Guarrera MD | Rutgers New Jersey Medical School
Novel Targets in Pancreas Cancer
William G. Hawkins MD | Washington University in St. Louis
3:30pm - 4:00pm
Afternoon Beverage Break, Exhibit & ePoster Viewing
Americana 4
4:00pm - 5:00pm
Leslie H. Blumgart Historical Lecture
Americana 1/2
Introduction
Katy Morgan MD | Medical University of South Carolina
A Pancreas Odyssey
David B. Adams MD | Medical University of South Carolina
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 72 2/22/18 9:13 PM
73AHPBA 2018 ANNUAL MEETING
5:00pm - 6:30pm
Women in Surgery | Navigating the Dual Career Waters
Cowrie 1/2
Moderators: Rebecca M. Minter, MD | University of Wisconsin;
Cristina Ferrone MD | Massachusetts General Hospital
Navigating the Tale of Two Cities
Susan L. Orloff MD | Oregon Health & Science University
The Nonportable Spouse
Rebekah R. White MD | University of California San Diego
HPB Training: A South American Marriage Perspective
Patricia A. Rebolledo MD | Hospital San Borja Arriaran
5:00pm - 6:30pm
State of the Art Symposium | Current Management of Colorectal Liver
Metastases
Americana 3
Moderators: Michael G. House MD | Indiana University School of Medicine;
Felipe J. Coimbra MD | AC Camargo Cancer Center
Resectable Liver Mets - Resect or Chemo First?
Rene Adam MD | Paul Brousse Hospital
Synchronous Rectal Metastasis: Algorithm
Moises Cukier MD | National Cancer Institute - Panama
Understanding Steatohepatitis and How to Tackle It
Yuman Fong MD | City of Hope
Gene Sequencing, Mutations and Prediction Models
Nicholas Vauthey MD | MD Anderson Cancer Center
Current Role of HIPEC with Colorectal Cancer
Kaitlyn J. Kelly MD | UC San Diego
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 73 2/22/18 9:13 PM
74 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
5:00pm - 6:30pm
Video Session - Pancreas
Americana 1/2
Moderators: Matthew Weiss MD | Johns Hopkins Hospital; Sergio Lopez Torrez
MD, MSc | Hospital Roberto Calderon
5:00pm - 5:12pm
V 1. PANCREATICODUODENECTOMY WITH MESOCAVAL SHUNT FOR
LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA
Presenter: Eve Simoneau MD, PhD | The University of Texas MD Anderson
Cancer Center
5:12pm - 5:24pm
V 2. LAPAROSCOPIC PUESTOW PROCEDURE AFTER OPEN WHIPPLE
FOR PRIMARY PANCREATIC DUCT STONE
Presenter: Armando Rosales MD | Cleveland Clinic Florida
5:24pm - 5:36pm
V 3. ROBOTIC TRANSDUODENAL APPROACH TO A LARGE
PERIAMPULLARY SESSILE TUBULOVILLOUS ADENOMA
Presenter: Robert Simon MD | Cleveland Clinic Foundation
5:36pm - 5:48pm
V 4. LAPAROSCOPIC ROUX-EN-Y LONGITUDINAL PANCREATICO-
JEJUNOSTOMY FOR CHRONIC OBSTRUCTION OF THE MAIN
PANCREATIC DUCT
Presenter: Fabio Makdissi MD | University of Sao Paulo
5:48pm - 6:00pm
V 5. PANCREATO-ENTERIC RECONSTRUCTION FOLLOWING ROBOTIC
PANCREATO-DUODENECTOMY. IS ONE TYPE OF RECONSTRUCTION
BETTER THAN THE OTHER?
Presenter: Eduardo Fernandes MD, PhD | University of Illinois at Chicago
6:00pm - 6:12pm
V 6. SUTURE-LESS BINDING PANCREATICOGASTROSTOMY : A VIDEO
DEMOSTRATION
Presenter: Phani Krishna Ravula MS, MRCS, MCh | Pace hospitals
6:12pm - 6:24pm
V 7. Extended hepatectomy with IVC Replacement using Venous Bypass
Presenter: Daniel Cherqui MD | Paul Brousse Hospital - Université Paris Sud
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 74 2/22/18 9:13 PM
75AHPBA 2018 ANNUAL MEETING
6:30pm - 7:00pm
Women in Surgery Reception
Cowrie Foyer
6:30pm - 7:30pm
AHPBA Cocktail Reception in Exhibit Hall
Americana Foyer and Americana 4
7:30pm - 10:00pm
AHPBA Congress Banquet
Americana Lawn
FRIDAY, MARCH 9, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 75 2/22/18 9:13 PM
76 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
6:30am - 6:00pm
Registration Open
Rotunda East
6:45am - 8:00am
Continental Breakfast in Exhibit Hall
Americana 4
7:00am - 8:00am
Professor Rounds | The Difficult Bile Duct
Cowrie 1/2
Moderators/Speakers:
Jeffrey S. Barkun MD | McGill University Health Centre
Jean C. Emond MD | Columbia University and The New York
Presbyterian Hospital
7:00am - 8:00am
Professor Rounds | Developing a Career in HPB Surgery? Chair’s Perspective
Periwinkle
Moderators/Speakers:
Lynt B. Johnson MD | Medstar Georgetown University Hospital
David C. Linehan MD | University of Rochester Medical Center
Jennifer F. Tseng MD, MPH | Boston University School of Medicine
7:00am - 8:00am
Professor Rounds | Technical Pearls and Disasters During Whipple Procedure
Poinciana 1/2
Moderators/Speakers:
Syed A. Ahmad MD | University of Cincinnati
Douglas B. Evans MD | Medical College of Wisconsin
Juan M. Sarmiento MD | Emory University
7:00am - 8:00am
Professor Rounds | Assessing Marginal Livers and How to Transplant Them
Poinciana 3/4
Moderators/Speakers:
Benjamin Samstein MD | Weill Cornell Medicine
Joe Tector MD, PhD | University of Alabama at Birmingham
Mario Vilatoba MD | Instituto Nacional de Ciencias Medicas y Nutricion
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 76 2/22/18 9:13 PM
77AHPBA 2018 ANNUAL MEETING
7:30am - 9:00am
Mini Oral Sessions | Monitor 1 HPB Transplant
Americana Foyer
Moderator: Juan Rocca MD | Montefiore Medical Center
7:30am - 7:35am
MO 76. IMPLEMENTATION OF CLINICALLY MEANINGFUL LAB
PROTOCOL: UTILIZING PREDICTIVE ANALYTICS TO GUIDE QUALITY
IMPROVEMENT INITIATIVES FOR PANCREATICODUODENECTOMY
AND HEPATECTOMY PATIENTS
Presenter: Kendra Tezber BSN, RN | Carolinas HealthCare System
7:35am - 7:40am
MO 77. SAFETY OF INTRAOPERATIVE BLOOD SALVAGE DURING
LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR
CARCINOMA; SYSTEMATIC REVIEW AND META-ANALYSIS
Presenter: Vera Rutten MBBS | Erasmus MC
7:40am - 7:45am
MO 78. HIGHEST OVERALL NEUTROPHIL TO LYMPHOCYTE RATIO
ON WAITING LIST PREDICTS RECURRENCE-FREE SURVIVAL IN LIVER
TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA
Presenter: John McVey BA | Cleveland Clinic Foundation
7:45am - 7:50am
MO 79. RECOMMENDATIONS OF AN INTERNATIONAL
MULTIDISCIPLINARY COMMITTEE ON STANDARDS FOR REPORTING
OUTCOMES OF TREATING BILIARY INJURIES
Presenter: Steven Strasberg MD, PhD | Washington University
7:50am - 7:55am
MO 80. LONG-TERM OUTCOMES OF CHANGE IN INSURANCE
COVERAGE AFTER LIVER TRANSPLANTATION
Presenter: Clifford Akateh MD | The Ohio State University and Nationwide
Children’s Hospital
7:55am - 8:00am
MO 81. SLEEVE GASTRECTOMY DECREASES THE INCIDENCE OF
METABOLIC SYNDROME IN OBESE POST-LIVER TRANSPLANT
PATIENTS
Presenter: Andrew Jung MD | University of Cincinnati
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 77 2/22/18 9:13 PM
78 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
8:00am - 8:05am
MO 82. LIVER TRANSPLANTATION BY REFRACTORY’S ASCITES
AND ITS CORRELATION WITH THE PRESENCE OF HEPATOCELLULAR
CARCINOMA
Presenter: Andre Gorgen MD | University of Campinas
8:05am - 8:10am
MO 83. ELEVATED RED CELL DISTRIBUTION WIDTH AND OUTCOMES
IN ADVANCED STAGE HCC AT LIVER TRANSPLANT
Presenter: Jacentha Buggs MD | Tampa General Hospital
8:10am - 8:15am
MO 84. LIVER SIZE MISMATCH IN DECEASED DONOR LIVER
TRANSPLANTATION
Presenter: Jacentha Buggs MD | Tampa General Hospital
8:15am - 8:20am
MO 85. WHEN OBSERVED DOES NOT GO AS EXPECTED: DEVASTATING
TRAJECTORIES IN HEPATOBILIARY SURGERY
Presenter: Lindsay Gil BS, BA | Loyola University Medical Center
8:20am - 8:25am
MO 86. BILIARY COMPLICATIONS AFTER PEDIATRIC LIVER
TRANSPLANTATION
Presenter: Adeel Khan MD, MPH | Washington University
8:25am - 8:30am
MO 87. NATIONWIDE OUTCOMES AFTER SURGERY FOR BENIGN
HEPATIC TUMORS
Presenter: Scott Revell MD | University of Miami Miller School of Medicine
8:30am - 8:35am
MO 88. ASSOCIATION BETWEEN DONOR HYPERNATREMIA AND
LIVER TRANSPLANT GRAFT FUNCTION
Presenter: Carlos Florez-Zorrilla MD | Centro Medico Nacional
8:35am - 8:40am
MO 89. THE EFFECT OF DONOR RACE-MATCHING ON OVERALL
SURVIVAL FOR AFRICAN AMERICAN PATIENTS UNDERGOING LIVER
TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA
Presenter: Jack Silva BS | Medical College of Wisconsin
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 78 2/22/18 9:13 PM
79AHPBA 2018 ANNUAL MEETING
8:40am - 8:45am
MO 90. SURVIVAL AND HCC RECURRENCE AFTER LIVER TRANSPLANT
DUE TO NASH RELATED HCC VS. NON-NASH RELATED HCC
Presenter: Julio Sokolich M.D. | Tampa General Hospital
8:45am - 8:50am
MO 91. INCISIONAL HERNIA AFTER LIVER TRANSPLANTATION
Presenter: Heidy Cos MD | Washington University
8:50am - 8:55am
MO 92. LAPAROSCOPIC FREY PROCEDURE. WHAT ARE THE
POTENTIAL CONTRAINDICATIONS ?
Presenter: Roman Izrailov MD | Moscow Clinical Scientific Centre
8:55am - 9:00am
MO 93. DISTAL PANCREATECTOMY FOR PANCREATITIS: DIVERSE
DISEASE WITH DISMAL OUTCOMES
Presenter: William Lancaster MD | Medical University of South Carolina
7:30am - 9:00am
Mini Oral Sessions | Monitor 2 HCC
Americana Foyer
Moderator: Shawn Pelletier MD | University Of Virginia Health System
7:30am - 7:35am
MO 94. OUTCOMES FOLLOWING TRANSARTERIAL EMBOLIZATION
FOR HEPATOCELLULAR CARCINOMA WITH COMPLETE RADIOLOGIC
RESPONSE
Presenter: Michele Babicky MD | Memorial Sloan Kettering Cancer Center
7:35am - 7:40am
MO 95. A COMPARISON OF PRESENTATION AND OUTCOME IN
PATIENTS WITH HEPATOCELLULAR CANCER FROM NONALCOHOLIC
STEATOHEPATITIS AND VIRAL HEPATITIS ETIOLOGIES
Presenter: Caitlin Hester MD | University of Texas Southwestern
7:40am - 7:45am
MO 96. CONDITIONAL PROBABILITY OF SURVIVAL IN PATIENTS WITH
SPONTANEOUS TUMOR RUPTURE ON HEPATOCELLULAR CARCINOMA
AFTER PARTIAL HEPATECTOMY: A PROPENSITY SCORE MATCHING
ANALYSIS
Presenter: Qian Zhu MD, PhD | Zhongda Hospital
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 79 2/22/18 9:13 PM
80 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
7:45am - 7:50am
MO 97. OPTIMIZING CANCER CARE FOR HEPATOCELLULAR
CARCINOMA AT A SAFETY-NET HOSPITAL: THE VALUE OF A
MULTIDISCIPLINARY DISEASE MANAGEMENT TEAM
Presenter: Grace Duininck BA | Emory University
7:50am - 7:55am
MO 99. GENDER DIFFERENCES IN HEPATOCELLULAR CANCER:
SHOULD FEMALES WITH NONALCOHOLIC FATTY LIVER DISEASE AND
STEATOHEPATITIS UNDERGO SURVEILLANCE FOR HEPATOCELLULAR
CANCER?
Presenter: Eric Wu BS | John A. Burns School of Medicine, University of
Hawaii at Manoa
7:55am - 8:00am
MO 100. INVESTIGATING THE BREATH METABOLOME AS A
DIAGNOSTIC TOOL FOR HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC PATIENTS
Presenter: Lou-Anne Acevedo-Moreno MD | Cleveland Clinic Foundation
8:00am - 8:05am
MO 101. RISK FACTORS FOR VERY EARLY RECURRENCE OF
HEPATOCELLULAR CARCINOMA: A RETROSPECTIVE REVIEW
Presenter: Robert Simon MD | Cleveland Clinic Foundation
8:05am - 8:10am
MO 102. UNRAVELLING THE COMPLEXITY MYTH FOR LAPAROSCOPIC
RIGHT HEPATECTOMY
Presenter: Salila Hashmi MD | Emory University
8:10am - 8:15am
MO 103. SELECTIVE LYMPH NODE SAMPLING IN RESECTABLE
HEPATOCELLULAR CARCINOMA: NATIONAL PRACTICE PATTERNS
AND NODE POSITIVITY RATES
Presenter: Andrew Lee MD, PhD | The University of Texas MD Anderson
Cancer Center
8:15am - 8:20am
MO 104. SOCIOECONOMIC FACTORS INCLUDING RACE INCREASE
ODDS OF LATE STAGE DIAGNOSIS OF HCC
Presenter: Marco Aru MS | University of Mississippi Medical Center
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 80 2/22/18 9:13 PM
81AHPBA 2018 ANNUAL MEETING
8:20am - 8:25am
MO 105. OUTCOMES AND PREDICTORS OF MORTALITY AFTER
LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA WITH
MACROVASCULAR INVASION: A COHORT STUDY
Presenter: Andre Gorgen MD | University Health Network, Toronto General
Hospital
8:25am - 8:30am
MO 106. A REAL-WORLD APPLICATION OF YTTRIUM90
TRANSARTERIAL RADIOEMBOLIZATION FOR HEPATOCELLULAR
CARCINOMA
Presenter: Kliment Bozhilov MD | John A. Burns School of Medicine,
University of Hawaii at Manoa
8:30am - 8:35am
MO 107. IMPLICATIONS OF UNPLANNED CONVERSION TO AN
OPEN PROCEDURE DURING LAPAROSCOPIC LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA
Presenter: Zachary Stiles DO | University of Tennessee Health Science
Center
8:35am - 8:40am
MO 109. REGIONAL UTILIZATION OF SURGERY AND SURVIVAL IN
PATIENTS WITH EARLY STAGE HEPATOCELLULAR CARCINOMA
Presenter: Grace Lee MD | Massachusetts General Hospital
8:40am - 8:45am
MO 110. PREDICTION OF MICROVASCULAR INVASION OF
HEPATOCELLULAR CARCINOMA IN LIVER TRANSPLANTATION
USING QUANTITATIVE PARAMETERS IN DYNAMIC COMPUTED
TOMOGRAPHY.
Presenter: Elaine Ataide PhD | University of Campinas
8:45am - 8:50am
MO 111. SURGICAL RESECTION OF HEPATOCELLULAR CARCINOMA
IN THE CIRRHOTIC PATIENT: ANATOMIC VERSUS NON-ANATOMIC
RESECTION?
Presenter: Anthony Scholer MD, MBS | Rutgers University
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 81 2/22/18 9:13 PM
82 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
7:30am - 9:00am
Mini Oral Sessions | Monitor 3 HPB Education Cost
Americana Foyer
Moderator: M.B. Majella Doyle MD, MBA | Washington University
7:30am - 7:35am
MO 112. THE LATIN AMERICAN HPB CONSORTIUM OF
EDUCATION AND RESEARCH (LAHCER): A PILOT SURVEY OF
HEPATOPANCREATOBILIARY TRAINING IN LATIN AMERICA
Presenter: Ismael Dominguez Rosado MD, MSc | Instituto Nacional de
Ciencias Médicas y Nutrición, Hospital Italiano de Buenos Aires, Hospital
General de México, Corporación Médica Monte Sinai, Hospital Das Clnicas
FMUSP, Hospital A Beneficiencia Portugues
7:35am - 7:40am
MO 113. WHAT DO HPB FELLOWS EXPECT OF THEIR TRAINING: A
SURVEY OF INCOMING HPB FELOWS AT THE BEGINNING OF THEIR
FELLOWSHIP.
Presenter: Spyridon Pagkratis MD | Methodist Richardson Medical Center
7:40am - 7:45am
MO 114. IMPLEMENTING QUALITY ASSURANCE FOR PANCREATIC
CANCER WITHIN AN INTEGRATED HEALTH SYSTEM
Presenter: Daniel Solomon MD | Icahn School of Medicine at Mount Sinai
7:45am - 7:50am
MO 115. THE ADHERENCE TO CHOLECYSTECTOMY TIMING
GUIDELINES AND ITS EFFECT ON HEALTHCARE AND PATIENT
CENTERED OUTCOMES
Presenter: Nourah Al-Beeshi | King Saud University
7:50am - 7:55am
MO 116. PATIENT-SPECIFIC PREDICTORS OF FAILURE TO RESCUE
AFTER MAJOR HEPATECTOMY
Presenter: Elizabeth Gleeson MD, MPH | Lewis Katz School of Medicine at
Temple University
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 82 2/22/18 9:13 PM
83AHPBA 2018 ANNUAL MEETING
7:55am - 8:00am
MO 117. TAILORED MULTISTAGE MINIMALLY INVASIVE MANAGEMENT
OF RESECTABLE STAGE IV COLORECTAL CANCER OFFERS OPTIMAL
POSTOPERATIVE OUTCOMES AND LONG-TERM SURVIVAL: A
PROPENSITY-SCORE WEIGHTING ANALYSIS
Presenter: Claire Goumard MD | The University of Texas MD Anderson
Cancer Center
8:00am - 8:05am
MO 118. EFFICACY AND LIMITATIONS OF 68-GALLIUM DOTATATE
PET/CT FOR NEUROENDOCRINE TUMORS: CLINICAL EXPERIENCE
FOLLOWING FDA APPROVAL
Presenter: Ryan Griffith MD | Saint Joseph Hospital
8:05am - 8:10am
MO 119. THE BENEFIT OF MINIMALLY INVASIVE
PANCREATICODUODENECTOMY ON ENHANCED RECOVERY
IS RESTRICTED TO PATIENTS WHO AVOID POSTOPERATIVE
COMPLICATIONS: A NSQIP ANALYSIS
Presenter: Dominic Sanford MD, MPHS | Washington University
8:10am - 8:15am
MO 120. DISTAL PANCREATECTOMY WITHOUT INTRAPERITONEAL
DRAINAGE: A COST-EFFECTIVE ALTERNATIVE TO ROUTINE
DRAINAGE.
Presenter: Felipe Maegawa MD, MS | Southern Arizona VA Health Care
System/ University of Arizona
8:15am - 8:20am
MO 121. ELDERLY DISPARITIES IN UTILIZATION AND ACCESS TO
TECHNOLOGY IN AN URBAN HEPATOPANCREATOBILIARY SURGICAL
PRACTICE
Presenter: John Hardaway MD, PhD | Roger Williams Medical Center
8:20am - 8:25am
MO 122. COMPARATIVE OUTCOMES OF EARLY AND
STANDARD DISCHARGE IN PATIENTS UNDERGOING
PANCREATODUODENECTOMY
Presenter: Gautam Sharma MD | Cleveland Clinic Foundation
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 83 2/22/18 9:13 PM
84 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
8:25am - 8:30am
MO 123. ACADEMIC RANK IN HEPATOPANCREATICOBILIARY
SURGEONS: IDENTIFYING BENCHMARKS
Presenter: Amit Khithani MD | City of Hope Cancer Center
8:30am - 8:35am
MO 124. RISK FACTORS FOR 30 DAY READMISSION RATES AFTER
HEPATECTOMY AND PANCREATECTOMY FOR BENIGN DISEASE, AN
ACS NSQIP DATABASE REVIEW.
Presenter: Cara Lyle MD | West Virginia University
8:35am - 8:40am
MO 125. INTEREST IN CAREER IN HEPATOPANCREATOBILIARY
SURGERY AND DIFFERENCES BY GENDER IN CHILEAN GENERAL
SURGERY RESIDENTS -RESULTS OF A NATIONAL SURVEY
Presenter: Diego Garcia MD | Hospital San Borja Arriaran
8:40am - 8:45am
MO 126. POST-HOC VIDEO REVIEW OF ROBOTIC
PANCREATICODUODENECTOMY TO PREDICT CIRCUMFERENTIAL
MARGIN POSITIVITY IN PANCREATIC ADENOCARCINOMA
Presenter: Brian Boone MD | University of Pittsburgh
8:45am - 8:50am
MO 127. PREDICTION ON SURGICAL OUTCOMES OF
VIDEOLAPAROSCOPIC CHOLECYSTECTOMY IN ELDERLY PATIENTS
USING COMORBIDITY COMBINED SCORE
Presenter: Vitor Carminatti Romano MS | Hospital das Clinicas of University
of Sao Paulo
8:50am - 8:55am
MO 128. OUTCOME OF 164 PATIENTS WITH IATROGENIC BILIARY
STRICTURE SUBMITTED TO SURGICAL REPAIR IN A SPECIALIZED
CENTER
Presenter: Estela Figueira MD, PhD | Hospital das Clinicas of University of
Sao Paulo
8:55am - 9:00am
MO 129. DOES FELLOW LEVEL OF TRAINING IMPACT OUTCOMES
AFTER DECEASED DONOR LIVER TRANSPLANTATION?
Presenter: Sandra Garcia-Aroz MD | Washington University
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 84 2/22/18 9:13 PM
85AHPBA 2018 ANNUAL MEETING
7:30am - 9:15am
Mini Oral Sessions | Monitor 4 Pancreas
Americana Foyer
Moderator: Alexander Parikh MD, MPH | University of South Carolina, Greenville
7:30am - 7:35am
MO 130. LAPAROSCOPIC TRANSGASTRIC NECROSECTOMY
REDUCES RE-INTERVENTION AND MORBIDITY COMPARED TO OPEN
NECROSECTOMY
Presenter: Patrick Worth MD | Stanford University
7:35am - 7:40am
MO 131. A SINGLE INSTITUTION’S FIRST 100 ROBOTIC
PANCREATICODUODENECTOMIES: A PRODUCT OF THE INEVITABLE
SHIFT TOWARDS MINIMALLY INVASIVE SURGERY
Presenter: Alexander Rosemurgy MD | Florida Hospital, Tampa
7:40am - 7:45am
MO 132. PANCREATODUODENECTOMY IN THE CIRRHOTIC PATIENT:
PREDICTORS OF OUTCOME.
Presenter: James Butler MD, PhD | Indiana University
7:45am - 7:50am
MO 133. RISK FACTORS FOR DEVELOPING DEEP VENOUS
THROMBOSIS & PULMONARY EMBOLISM IN PATIENTS UNDERGOING
PANCREATICODUODENECTOMY
Presenter: Casey Allen MD | University of Miami Miller School of Medicine
7:50am - 7:55am
MO 134. EXPERIENCE OF 215 TOTALLY LAPAROSCOPIC
PANCREATODUODENECTOMIES
Presenter: Magomet Baychorov MD | Moscow Clinical Scientific Centre
7:55am - 8:00am
MO 135. INITIAL REPORTING OF OVERALL SURVIVAL OF THE AHPBA
PANCREATIC REGISTRY
Presenter: Robert CG Martin MD, PhD | University of Louisville School of
Medicine
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 85 2/22/18 9:13 PM
86 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
8:00am - 8:05am
MO 136. DOES DRAIN SUCTION INFLUENCE THE INCIDENCE OF
CLINICALLY RELEVANT POSTOPERATIVE PANCREATIC FISTULA
Presenter: Jason Liu MD, MS | Lewis Katz School of Medicine at Temple
University
8:05am - 8:10am
MO 137. LAPAROSCOPIC VERSUS ROBOTIC-ASSISTED LEFT
PANCREATECTOMY FOR ADENOCARCINOMA AT A HIGH VOLUME,
MINIMALLY INVASIVE CENTER
Presenter: William Lyman MD | Carolinas HealthCare System
8:10am - 8:15am
MO 138. OPEN PANCREATIC DÉBRIDEMENT: CONTEMPORARY
OUTCOMES IN CHANGING TIMES
Presenter: Thomas Maatman MD | Indiana University
8:15am - 8:20am
MO 139. COMPLIANCE WITH ERAS PROTOCOLS IMPROVES OVERALL
AND DISEASE FREE SURVIVAL AFTER PANCREATICODUODENECTOMY
Presenter: Michael Passeri MD | Carolinas HealthCare System
8:20am - 8:25am
MO 140. ANTIPLATELET THERAPY AFTER
PANCREATICODUODENECTOMY WITH PORTAL VEIN RESECTION MAY
BE THE OPTIMAL ANTICOAGULANT
Presenter: Amit Sastry MD | Carolinas HealthCare System
8:25am - 8:30am
MO 141. IMPROVED MORTALITY AFTER PANCREATECTOMY IN THE
MODERN ERA
Presenter: Michael Lidsky MD | Memorial Sloan Kettering Cancer Center
8:30am - 8:35am
MO 142. PREOPERATIVE PANCREATIC GLAND RADIODENSITY
PREDICTS LEAKS IN DISTAL PANCREATECTOMY, BUT NOT
PANCREATICODUODENECTOMY.
Presenter: Patrick Worth MD | Oregon Health and Sciences University
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 86 2/22/18 9:13 PM
87AHPBA 2018 ANNUAL MEETING
8:35am - 8:40am
MO 143. EARLY VERSUS LATE DRAIN REMOVAL AFTER WHIPPLE
PROCEDURE
Presenter: Konstantinos Zorbas MD | Lewis Katz School of Medicine at
Temple University Hospital
8:40am - 8:45am
MO 144. DIFFERENCES IN THE PATTERN AND TIMING OF
RECURRENCE IN PATIENTS AFTER UPFRONT OR POST-NEOADJUVANT
PANCREATECTOMY FOR PANCREATIC DUCTAL ADENOCARCINOMA
Presenter: Vincent P. Groot MD | Johns Hopkins University School of
Medicine
8:45am - 8:50am
MO 145. PATIENTS OVER AGE 70 AT HIGHER RISK FOR PERIOPERATIVE
COMPLICATIONS AFTER DISTAL PANCREATECTOMY FOR
NEUROENDOCRINE AND CYSTIC NEOPLASMS
Presenter: Rajesh Ramanathan MD | Virginia Commonwealth University
Medical Center
8:50am - 8:55am
MO 146. TRAVEL DISTANCE AFFECTS RATES AND REASONS FOR
READMISSION AFTER PANCREATECTOMY
Presenter: Rachel Simpson MD | Indiana University
8:55am - 9:00am
MO 147. THE LONG-TERM OUTCOMES OF RADICAL
PANCREATOSPLENECTOMY FOR PATIENTS WITH DISTAL PANCREATIC
ADENOCARCINOMA
Presenter: Genki Watanabe MD | Cancer Institute Hospital, Japanese
Foundation for Cancer Research
9:00am - 9:05am
MO 148. DABIGATRAN (PRADAXA) IS SAFE FOR EXTENDED VENOUS
THROMBOEMBOLISM PROPHYLAXIS AFTER PANCREATIC ONCOLOGIC
SURGERY
Presenter: M. Farzan Rashid BS | Columbia University
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 87 2/22/18 9:13 PM
88 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
9:05am - 9:10am
MO 149. THE IMPACT OF TUMOR DIFFERENTIATION ON
PERIOPERATIVE OUTCOMES AND PATTERNS OF RECURRENCE
FOLLOWING PREOPERATIVE THERAPY FOR RESECTABLE PANCREATIC
ADENOCARCINOMA
Presenter: James Lindberg MD | The University of Texas MD Anderson
Cancer Center
9:10am - 9:15am
MO 150. PREOPERATIVE IMAGING CHARACTERISTICS PREDICT
POOR SURVIVAL AND INADEQUATE RESECTION FOR LEFT-SIDED
PANCREATIC ADENOCARCINOMA: A MULTI-INSTITUTIONAL
ANALYSIS
Presenter: Farzad Alemi MD | Virginia Mason Medical Center
8:00am - 9:00am
State of the Art International Symposium | ALPPS for Cancer
Americana 1/2
Moderators: William C. Chapman MD | Washington University School of
Medicine; Javier C. Lendoire MD, PhD | Hospital Dr C Argerich
Colorectal Metastases
Roberto Hernandez-Alejandro MD | University of Rochester
Transplantation After “Failed” ALPPS
Pierre-Alain Clavien MD PhD | University Hospital Zurich
Laparoscopic Version
Marcel Machado MD | University of Sao Paulo
8:00am - 9:00am
Oral Presentations 4: Pancreas II
Poinciana 1/2
Moderators: Claudemiro Quireze Jr MD, PhD | Federal University of Goiás;
Stephen Behrman MD | University of Tennessee Heath Science Center
8:00am - 8:12am
26. CALCIFICATIONS AND CYSTIC MORPHOLOGY ON PREOPERATIVE
IMAGING PREDICT SURVIVAL AFTER RESECTION OF PANCREATIC
NEUROENDOCRINE TUMORS
Presenter: Eleftherios Makris MD, PhD | Stanford University
Invited Discussant: Sameer Patel MD | University of Cincinnati Medical
Center
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 88 2/22/18 9:13 PM
89AHPBA 2018 ANNUAL MEETING
8:12am - 8:24am
27. CAN HIGH-VOLUME ANESTHESIOLOGISTS DECREASE
PERIOPERATIVE COSTS FOR PANCREATIC SURGERY?
Presenter: Abhineet Uppal MD | John Wayne Cancer Institute
Invited Discussant: Federico Aucejo MD | Cleveland Clinic
8:24am - 8:36am
28. TUMOR LOCATION PREDICTS PRESENCE OF HIGH GRADE
DYSPLASIA AND INVASIVE CARCINOMA IN INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASMS OF THE PANCREAS
Presenter: Stephanie Kerlakian BS | University of Cincinnati
Invited Discussant: Melissa Hogg MD, MS | UPMC
8:36am - 8:48am
29. ROBOTIC PANCREATODUODENECTOMY WITH VASCULAR
RESECTION: HOW STEEP IS THE LEARNING CURVE?
Presenter: Joal Beane MD | University of Pittsburgh Medical Center
Invited Discussant: Mike Kendrick MD | Mayo Clinic Rochester
8:48am - 9:00am
30. SELECTIVE PANCREATIC STENTING AND RECTAL INDOMETHACIN
IN HIGH-RISK ERCP PATIENTS RESULTS IN SIGNIFICANT DECREASE IN
POST-ERCP PANCREATITIS
Presenter: Wesley Jones MD | University of South Carolina School of
Medicine, Greenville
Invited Discussant: Alex Rosemurgy MD | University of Central Florida,
Florida Hospital Tampa
8:00am - 9:00am
Oral Presentations 5: Liver
Poinciana 3
Moderators: Sukru H. Emre MD | Yale School of Medicine;
Abhishek Mathur MD | Ochsner Clinic
8:00am - 8:12am
31. IN PATIENTS UNDERGOING HEPATIC RESECTION, IS THE LIVER
SURGERY COMPLEXITY SCORE A BETTER PREDICTOR OF CASE
COMPLEXITY AND POSTOPERATIVE MORBIDITY THAN THE
CONVENTIONAL MAJOR/MINOR CLASSIFICATION?
Presenter: Mohammed Al-Temimi MD, MPH | Kaiser Permanente, Los
Angeles Medical Center Invited Discussant: David Levi MD | Carolinas
Medical Center
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 89 2/22/18 9:13 PM
90 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
8:12am - 8:24am
32. IMPROVED PERFORMANCE WITH MINIMALLY INVASIVE LIVER
RESECTION: A SINGLE CENTER WESTERN EXPERIENCE WITH 1,062
CASES
Presenter: Forat Swaid MD | University of Pittsburgh Medical Center
Invited Discussant: Joseph Buell MD, MBA | Tulane University
8:24am - 8:36am
33. A MULTI-INSTITUTIONAL ANALYSIS OF MINIMALLY INVASIVE
LIVER RESECTIONS
Presenter: Alison Smith MD, PhD | Tulane University School of Medicine;
Carolinas Medical Center; City of Hope
Invited Discussant: Sean Cleary MD, MSC, MPH | Mayo Clinic
8:36am - 8:48am
34. STANDARDIZATION OF OPERATIVE TECHNIQUE IN
LAPAROSCOPIC RIGHT HEPATECTOMY: IMPROVING COST-VALUE
RELATIONSHIP THROUGH VALUE STREAM MAPPING
Presenter: Mohammad Raheel Jajja MD | Emory University
Invited Discussant: Clancy Clark MD | Wake Forest Baptist Health
8:48am - 9:00am
35. MULTIDISCIPLINARY, PERIOPERATIVE CARE BUNDLE
DECREASES SURGICAL SITE INFECTION IN PATIENTS UNDERGOING
SYNCHRONOUS COLORECTAL/LIVER RESECTION
Presenter: Lauren Tufts BA | Memorial Sloan Kettering Cancer Center
Invited Discussant: Susanne Warner MD | City of Hope Comprehensive
Cancer Center
9:00am - 10:00am
Betty & Henry Pitt Quality Oration
Americana 1/2
Introduction
Timothy Pawlik, MD, MPH, PhD | The Ohio State University
Achieving Surgical Quality: Observations from the American College of
Surgeons
Clifford Y. Ko MD, MS, MSHS, FACS, FASCRS | University of California-Los
Angeles/American College of Surgeons
10:00am - 10:30am
Morning Beverage Break, Exhibit & ePoster Viewing
Americana Foyer
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 90 2/22/18 9:13 PM
91AHPBA 2018 ANNUAL MEETING
10:30am - 12Noon
ASTS/AHPBA Joint Symposium: Multidisciplinary Management of HCC
Americana 1/2
Moderators: Christopher J. Sonnenday MD, MHS | University of Michigan;
Wellington Andraus MD, PhD | Sao Paulo University School of Medicine
Resect When You Can
Cristina Ferrone MD | Massachusetts General Hospital
Why Resect When You Can Ablate?
David A. Iannitti MD | Carolinas HealthCare System
Effectiveness of Liver Directed Therapy
Riad Salem MD, MBA | Northwestern University
Downstage and Then Transplant
Maria B. Doyle MD, MBA | Washington University School of Medicine
Case Presentations
10:30am - 12:00pm
Locally Advanced Pancreatic Cancer
Americana 3
Moderators: Syed A. Ahmad MD | University of Cincinnati Medical Center; Andre
Montagnini MD | Universidade de Sao Paulo, Brazil
Treatment Sequencing for Borderline and Locally Advanced Disease
Matthew Katz MD | UT MD Anderson Cancer Center
Novel Vascular Reconstruction Techniques
Mark J. Truty MD, MS | Mayo Clinic
Can Systematic Therapy Downstage Patients?
Davendra Sohal, MD | Cleveland Clinic
Role of Radiation for Borderline and Locally Advanced Disease
Joseph M. Herman MD | University of Texas MD Anderson Cancer Center
Role for IRE
Robert Martin MD, PhD | University of Louisville
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 91 2/22/18 9:13 PM
92 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
10:30am - 12:00pm
Video Session HPB
Cowrie 1/2
Moderators: Karim Halazun MD | Weill Cornell Medicine;
Eduardo Montalvo-Jave MD, PhD | Hospital General de Mexico
10:30am - 10:42am
V 8. LAPAROSCOPIC RESECTION OF CAUDATE LOBE. TECHNICAL
STRATEGIES FOR A DIFFICULT LIVER SEGMENT
Presenter: Marcel Autran Machado MD | University of Sao Paulo
10:42am - 10:54am
V 9. FULLY ROBOTIC LEFT HEPATECTOMY FOR HEPATOCELLULAR
CARCINOMA IN A PATIENT WITH HEPTAITIS B CIRRHOSIS
Presenter: Karim Halazun MD | Weill Cornell Medicine
10:54am - 11:06am
V 10. LAPAROSCOPIC RIGHT HEPATECTOMY FOR COMPLEX BILIARY
INJURY AFTER LAPAROSCOPIC CHOLECYSTECTOMY
Presenter: Marcel Autran Machado MD | University of Sao Paulo
11:06am - 11:18am
V 11. LEFT HEMIHEPATECTOMY WITH THROMBECTOMY
FROM INFERIOR VENA CAVA AND RIGHT ATRIUM UNDER
CARDIOPULMONARY BYPASS IN PATIENT WITH HEPATOCELLULAR
CARCINOMA
Presenter: Ruslan Alikhanov MD, PhD | Moscow Clinical Scientific Center
11:18am - 11:30am
V 12. LAPAROSCOPIC RIGHT CAUDATE LOBE MASS RESECTION
Presenter: Benjamin Farber MD | Montefiore Medical Center/Albert Einstein
College of Medicine
11:30am - 11:42am
V 13. LAPAROSCOPIC EXTENDED POSTERIOR SECTORECTOMY
FOR METASTATIC ADRENOCORTICAL CARCINOMA: A MINIMALLY
INVASIVE APPROACH TO PARENCHYMAL PRESERVATION
Presenter: Michael Lidsky MD | Memorial Sloan Kettering Cancer Center
11:42am - 11:54am
V 14. INTERCOSTAL AND GLISSONIAN PEDICLE APPROACH IN
LAPAROSCOPIC LIVER RESECTION FOR BILOBAR TUMORS
Presenter: Tadahiro Uemura MD, PhD | Alleghey Health Network
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 92 2/22/18 9:13 PM
93AHPBA 2018 ANNUAL MEETING
10:30am - 12:00pm
Oral Presentations 6: Large Databases
Poinciana 1/2
Moderators: Flavio Paterno MD, MPH | University of Cincinnati; Tun Jie MD |
University of Arizona
10:30am - 10:42am
36. ANATOMICAL HEPATIC RESECTION VERSUS WEDGE RESECTION
FOR GALLBLADDER CANCER: ANALYSIS OF MULTI-CENTER DATABASE
Presenter: Mohammed Al-Temimi MD, MPH | Kaiser Permanente, Los
Angeles Medical Center Invited Discussant: Mariano Gimenez MD, PhD |
University of Buenos Aires
10:42am - 10:54am
37. WOUND PROTECTORS MITIGATE SUPERFICIAL SURGICAL SITE
INFECTIONS AFTER PANCREATODUODENECTOMY
Presenter: Jason Liu MD, MS | Lewis Katz School of Medicine at Temple
University
Invited Discussant: Chad Ball MD, MSC | University of Calgary
10:54am - 11:06am
38. DEFINING A LIVER TRANSPLANT BENEFIT THRESHOLD FOR
MODEL FOR END STAGE LIVER DISEASE
Presenter: Eliza W. Beal MD | The Ohio State University
Invited Discussant: Peter Kim MD | University of British Columbia
11:06am - 11:18am
39. LIFE EXPECTANCY AFTER PANCREATIC CANCER RESECTION,
ACCORDING TO HOSPITAL OPERATIVE MORTALITY
Presenter: Mustafa Raoof MD, MS | City of Hope Cancer Center
Invited Discussant: Shishir Maithel MD | Emory University
11:18am - 11:30am
40. ANALYSIS OF OUTCOME OF OPEN AND MINIMAL INVASIVE
PANCREATICODUODENECTOMY USING NSQIP.
Presenter: Hassan Aziz MD | Banner University Medical Center
Invited Discussant: Sharona Ross MD | Florida Hospital, Tampa
11:30am - 11:42am
41. PANCREATECTOMY AND BODY MASS INDEX: AN INTERNATIONAL
EVALUATION OF CUMULATIVE POSTOPERATIVE COMPLICATIONS
USING THE COMPREHENSIVE COMPLICATIONS INDEX
Presenter: Brendan Lovasik MD | Emory University
Invited Discussant:
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 93 2/22/18 9:13 PM
94 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
11:42am - 11:54am
42. LOCAL REFERRAL OF PANCREATECTOMY PATIENTS TO IMPROVE
SURGICAL QUALITY
Presenter: Margaret Smith MD | University of Michigan
Invited Discussant: Matthew Katz MD | University of Texas, MD Anderson
Cancer Center
12:00pm - 12:30pm
Industry Lunch Symposium - Thank you BTG
Poinciana 3/4
12:00pm - 12:30pm
Lunch in Exhibit Hall
Americana 4
12:30pm - 2:00pm
Fellows Jeopardy
Americana 1/2
12:30pm - 2:00pm
Optimal Margins in HPB Malignancy
Americana 3
Moderators: David Kooby MD | Emory University; Carlos Chan MD | National
Institute of Medical Sciences
Pancreas Cancer: Margin is Critical
Christopher L. Wolfgang MD, PhD | Johns Hopkins
Pancreas Cancer: Margin Doesn’t Matter
David Kooby MD | Emory University
IPMN: Need a Negative Margin
Giuseppe Malleo MD, PhD | Unit of General and Pancreatic Surgery,
University of Verona Hospital Trust
IPMN: Less is More
Nipun B. Merchant MD | University of Miami Hospital
Colorectal Liver Mets: 1cm is mandatory
Flavio G. Rocha MD | Virginia Mason Medical Center
Colorectal Liver Mets: 1mm is Fine
Juan C. Sabogal MD, MSc | Mederi Hospital and San Ignacio Hospital
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 94 2/22/18 9:13 PM
95AHPBA 2018 ANNUAL MEETING
12:30pm - 2:00pm
Fellows Jeopardy
Americana 1/2
Moderator: Shishir K. Maithel MD | Emory University
12:30pm – 2:00pm
Consensus Conference | The Role of Somatostatin Analogues in Pancreas
Surgery
Poinciana 1/2
Moderator: John Mansour MD | University of Texas Southwestern Medical Center
Audience Participation
Ajay Maker MD | University of Illinois at Chicago
Introduction
John Mansour MD | University of Texas Southwestern Medical Center
Delphi Process Methods
Natalie Coburn MD | The Odette Cancer Centre
State of the Literature
Charles St. Hill MD | UNLV School of Medicine
Initial Survey Design
Susanne Warner MD | City of Hope
The Consensus Process
Quan Ly MD | University of Nebraska Medical Center
Final Survey Results and Consensus Statements
Clifford Cho MD | University of Michigan Medical School
Audience Participation
Ajay Maker MD | University of Illinois at Chicago
Discussion
Lessons Learned and Future Plans for AHPBA Consensus Conference
John Mansour MD | University of Texas Southwestern Medical Center
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 95 2/22/18 9:13 PM
96 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
1:00pm - 5:15pm
APP Symposium
Cowrie 1/2
Moderator: Jenna L. Jeganathan PA-C | Cleveland Clinic; Mary Beth Henry RN,
MS, CS, APNP | University of Wisconsin
1:00pm – 3:00pm
Pancreas Cyst Registry
Lan P. Vu PA-C | UT Southwestern Medical Center
Radiology for the HPB APP
Jennifer A. Flood ANP-NC | Memorial Sloan Kettering Cancer Center
Choledochal Cysts
Tanya Kintz DNP, FNP-BC, HNB-BC, AOCNP | Henry Ford Hospital
The Role of the APP in the Care of Liver Transplant Patients
Lacey Bittel PA-C | University of Cincinnati Medical Center
3:00pm - 3:30pm
Afternoon Beverage Break
Americana Foyer
3:30pm – 5:15pm
DVT Prophylaxis
Caitlin Brown NP | University of Pennsylvania
Quick Shot: GDA Bleeding after IRE Treatment of Locally-Advanced
Pancreatic Cancer
Nathan Ogilvie PA-C | Wake Forest Baptist Medical Center
Quick Shot: Pancreatitis…What Lies Beneath?
Veronica L. Coleman MPAS, PA-C | UT Southwestern Medical Center
Quick Shot: Reducing Cost in Healthcare
Morgan L. Bruno ACNP-BC | UT MD Anderson Cancer Center
Quick Shot: Locally Advanced Pancreatic Cancer and (IRE) Irreversible
Electroporation
Sarah Reed MHS, PA-C | Duke University
Quick Shot: Nurse Navigation: An Important Aspect of Multidisciplinary
Care for Hepatopancreaticobiliary Cancer Patients
Alyssa J. Chapates BSN, RN, OCN | Methodist Richardson Cancer Center
Keynote Address: Improving the Patient Experience
Emily R. Winslow MD, MS | University of Wisconsin
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 96 2/22/18 9:13 PM
97AHPBA 2018 ANNUAL MEETING
Panel Discussion:
Role of Co-Management of Patients with APP and Surgeon - Which Model
Works Best?
HCAHPs Scores/Patient’s Experience Scores - Do They Correlate with
Better Outcomes?
Patient Coordination/Negotiating Multidisciplinary Care
Interesting Cases to Underscore Collaborative Practice
Panelists: Ashley H. Seawright DNP, ACNP-BC | University of Mississippi
Medical Center; Cherese Lofton, RN | Cleveland Clinic
Lindsey Manos DHSc, PA-C | Johns Hopkins Hospital; Ann Parker CRNP |
George Washington University Hospital
2:00pm - 3:00pm
Presidential Invited Lecture
Americana 1/2
Introduction
Rebecca M. Minter MD | University of Wisconsin
The Diversity Bonus: How Cognitive and Identity Diversity Improve Outcomes
Scott E. Page | University of Michigan
3:00pm - 3:30pm
Afternoon Beverage Break
Americana Foyer
3:30pm - 5:00pm
Business of HPB Surgery: Why It’s Worth It
Americana 3
Moderators: Bryan M. Clary MD, MBA | UC San Diego; Mark S. Talamonti MD |
NorthShore University HealthSystem
Creation and Revenue of an HPB Unit
Melissa Hogg MD MS | University of Pittsburgh Medical Center
Assessing Value and Compensation for HPB Surgeons
Charles R. Scoggins MD, MBA | University of Louisville
Benefits of a Liver Transplant Program
Christopher D. Anderson MD | University of Mississippi of Medical Center
Building Volume, Growth, and Revenue Through Multidisciplinary Clinics
Richard Schulick MD, MBA | University of Colorado School of Medicine
Is It Worth It? Chair’s Perspective
Keith D. Lillemoe MD | Massachusetts General Hospital
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 97 2/22/18 9:13 PM
98 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
3:30pm - 5:00pm
Changing Paradigm of Necrotizing Pancreatitis
Americana 1/2
Moderators: Nicholas J. Zyromski MD | Indiana University School of Medicine;
Richard M. Charnley MD | Freeman Hospital
Frame the Issue
Nicholas J. Zyromski MD | Indiana University School of Medicine
GI Perspective
Gregory A. Cote MD, MS | Medical University of South Carolina
Percutaneous Approach / Step Up
Rajesh Gupta MD | Postgraduate Institute of Medical Education and Research
Surgical Approach: Open Necrosectomy
Jessica L. Cioffi MD | University of Florida
Surgical Approach: Minimally Invasive Approaches
Chad G. Ball MD, MSC | University of Calgary
3:30pm - 5:00pm
Oral Presentations 7: Basic Science
Poinciana 1/2
Moderators: Allan Tsung MD | University of Pittsburgh Medical Center; Juan
Sanabria MD, MSc | Marhsall University
3:30pm - 3:42pm
43. CD73 AS A NOVEL IMMUNE TARGET AND BIOMARKER IN
PANCREATIC ADENOCARCINOMA
Presenter: Nouredin Messaoudi MD | Centre hospitalier de l’Université de
Montréal
Invited Discussant: Jordan Cloyd MD | The Ohio State University
3:42pm - 3:54pm
44. COLLAGEN TARGETED MRI ACCURATELY MEASURES THE
DESMOPLASTIC RESPONSE TO FOLFIRINOX TREATMENT IN A MURINE
MODEL OF PANCREATIC CANCER
Presenter: Derek Erstad MD | Massachusetts General Hospital, Harvard
Medical School
Invited Discussant: Williams Hawkins MD | Washington University
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 98 2/22/18 9:13 PM
99AHPBA 2018 ANNUAL MEETING
3:54pm - 4:06pm
45. INDUCTION OF PD-L1 EXPRESSION IN PANCREATIC TUMOR
MICROENVIRONMENT BY IFN-Y: RATIONALE FOR PD-L1 THERAPY
COMBINATION WITH IRREVERSIBLE ELECTROPORATION THERAPY
Presenter: Young Hong MD | University of Louisville School of Medicine
Invited Discussant: Ryan Fields MD | Washington University
4:06pm - 4:18pm
46. LOCAL VERSUS CIRCULATING IMMUNE CELL POPULATIONS IN
PANCREATIC DUCTAL ADENOCARCINOMA PATIENTS
Presenter: Michael Gerber MD | University of Florida
Invited Discussant: Motaz Qadan MD, PhD | Massachusetts General
Hospital
4:18pm - 4:30pm
47. CHANGE IN CIRCULATING TUMOR DNA AFTER HEPATIC
RESECTION FOR METASTATIC COLORECTAL CANCER
Presenter: Raja Narayan MD, MPH | Memorial Sloan Kettering Cancer Center
Invited Discussant: Ted Welling MD | NYU Langone Health
4:30pm - 4:42pm
48. NOVEL CELL MEMBRANE CATION TRANSPORTER ASSOCIATED
WITH PLATINUM THERAPY RESISTANCE IN PANCREATIC
ADENOCARCINOMA IDENTIFIED THROUGH CRISPR/CAS9 LOSS-OF-
FUNCTION SCREEN
Presenter: Epameinondas Dogeas MD | University of Texas Southwestern
Invited Discussant: Ajay Maker MD | University of Illinois at Chicago
4:42pm - 4:54pm
49. THE EFFECTS OF P-NAK-TIDE AND SW033299 ON NASH
ASSOCIATED CIRRHOSIS IN THE RODENT.
Presenter: Matthew Schade MSc | Marshall University School of Medicine &
Case Western Reserve University School of Medicine
Invited Discussant: Martin Dib MD | University of Wisconsin, Madison
5:15pm - 6:00pm
AHPBA Business Meeting (Members Only)
Americana 1/2
6:15pm - 6:45pm
Advanced Practice Provider Reception
Americana Foyer
SATURDAY, MARCH 10, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 99 2/22/18 9:13 PM
100 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
6:30am - 7:30am
AHPBA Leadership & Chapter Presidents Breakfast Meeting
Crown Conch
7:30am - 8:30am
Continental Breakfast
Americana Foyer - The Rotunda
7:30am - 11:30am
Registration Open
Rotunda East
8:00am - 9:30am
Oral Presentations 8: HPB/Transplant
Americana 1
Moderators: Vinay Kapoor MD | SGPGIMS; T. Mark Earl MD | University of
Mississippi Medical Center
8:00am - 8:12am
50. PERIOPERATIVE BLOOD TRANSFUSIONS FOLLOWING HEPATIC
LOBECTOMY: A NATIONAL ANALYSIS OF ACADEMIC MEDICAL
CENTERS IN THE MODERN ERA
Presenter: Vikrom Dhar MD | University of Cincinnati
Invited Discussant: Tim Pawlik MD, MPH, PhD | The Ohio State University
Wexner Medical Center
8:12am - 8:24am
51. A GENETIC RISK NOMOGRAM FOR PATIENTS WITH COLORECTAL
LIVER METASTASES: THE CENTRAL ROLE OF BRAF MUTATIONAL
STATUS IN STRATIFYING OUTCOMES
Presenter: Georgios Antonios Margonis MD, PhD | Johns Hopkins University
School of Medicine Invited Discussant: Matthew Porembka MD | University
of Texas Southwestern Medical School
8:24am - 8:36am
52. DOUBLE LIGATION OF PORTAL AND HEPATIC VEINS ACHIEVES
HYPERTROPHY COMPARABLE TO ALPPS - A STUDY IN PIGS
Presenter: Erik Schadde MD | Rush University Medical Center
Invited Discussant: Asmund Fretland MD | Oslo University Hospital
SUNDAY, MARCH 11, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 100 2/22/18 9:13 PM
101AHPBA 2018 ANNUAL MEETING
8:36am - 8:48am
53. OPEN VERSUS LAPAROSCOPIC LIVER RESECTION FOR
COLORECTAL LIVER METASTASES LOCATED IN THE POSTERO-
SUPERIOR SEGMENTS: A SUB-GROUP ALAYSIS FROM THE OSLO-
COMET TRIAL
Presenter: Davit Aghayan MD | Oslo University Hospital
Invited Discussant: Emily Winslow MD | University of Wisconsin
8:48am - 9:00am
54. SERUM FACTOR V AS A PREDICTOR OF GRAFT DYSFUNCTION AND
MORTALITY AFTER LIVER TRANSPLANTATION
Presenter: Andre Gorgen MD | Hospital de Clinicas de Porto Alegre
Invited Discussant: Lucio Pereira MD | Hospital Brasilia
9:00am - 9:12am
55. POSITIVE CYSTIC DUCT STUMP AT INDEX CHOLECYSTECTOMY
IN INCIDENTAL GALLBLADDER CANCER IS A STRONG NEGATIVE
PROGNOSTICATOR EVEN IN PATIENTS WITHOUT RESIDUAL DISEASE
AT ONCOLOGIC RE-RESECTION
Presenter: Eduardo Vega MD | The University of Texas MD Anderson Cancer
Center and Hospital Sotero del Rio
Invited Discussant: Allan Tsung MD | University of Pittsburgh Medical
Center65.
9:12am - 9:24am
56. EVALUATION OF LIVER TRANSPLANT RESULTS WITH “LIVERS
THAT NOBODY WANTS”
Presenter: Emilio Quiñonez MD | Hospital el Cruce
Invited Discussant: Ashish Singhal MD | Fortis Hospital
8:00am - 9:30am
Oral Presentations 9: Pancreas III
Americana 2
Moderators: Susanne Warner MD | City of Hope Comprehensive Cancer Center;
Purvi Parikh MD | Kaiser Permanente
8:00am - 8:12am
57. IMPACT OF RECENT GUIDELINES ON OVERTREATMENT OF
ASYMPTOMATIC PANCREATIC CYSTIC LESIONS
Presenter: Katherine Baugh MD | Baylor College of Medicine
Invited Discussant: Kimberly Dalal MD |Palo Alto Medical Foundation
SUNDAY, MARCH 11, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 101 2/22/18 9:13 PM
102 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
8:12am - 8:24am
58. EFFECT OF VESSEL PRESERVATION ON SPLENIC VOLUME
AND FUNCTION IN PATIENTS WITH SPLEEN PERSERVING DISTAL
PANCREATECTOMIES.
Presenter: Lavanya Yohanathan MD | University of Toronto
Invited Discussant: Marcus Tan MBBS | Vanderbilt University Medical Center
8:24am - 8:36am
59. OUTCOMES AFTER PANCREATECTOMY WITH ROUTINE USAGE OF
PASIREOTIDE
Presenter: John Kunstman MD, MHS | Memorial Sloan Kettering Cancer
Center
Invited Discussant: Luke Schoeniger MD, PhD | University of Rochester
8:36am - 8:48am
60. PATHOLOGICAL COMPLETE RESPONSE TO CHEMOTHERAPY IN
PANCREATIC CANCER: FREQUENCY, PREDICTORS AND IMPACT ON
OVERALL SURVIVAL.
Presenter: Basem Azab MD | University of Miami Miller School of Medicine
Invited Discussant: Adam Yopp MD | University of Texas Southwestern
Medical School
8:48am - 9:00am
61. A PROSPECTIVE STUDY OF PASIREOTIDE IN PATIENTS
UNDERGOING PANCREATICODUODENECTOMY: A PROPENSITY SCORE
MATCHED ANALYSIS
Presenter: Dominic Sanford MD MPHS | Washington University
Invited Discussant: Dan Abbott MD | University of Wisconsin
9:00am - 9:12am
62. DOES PERIOPERATIVE FLUID RESUSCITATION IMPACT
PANCREATIC FISTULA RATES AFTER PANCREATICODUODENECTOMY?
Presenter: Leah Winer MD | University of Cincinnati
Invited Discussant: Charles Vollmer MD | University of Pennsylvania
9:12am - 9:24am
63. THE IMPACT OF FAILURE TO ACHIEVE SYMPTOM CONTROL
AFTER RESECTION OF FUNCTIONAL NEUROENDOCRINE TUMORS:
AN 8-INSTITUTION STUDY FROM THE US NEUROENDOCRINE TUMOR
STUDY GROUP
Presenter: Mohammad Zaidi MD, MS | Emory University
Invited Discussant: Heber Salvador de Castro Ribeiro MD | AC Camargo
Cancer Hospital
SUNDAY, MARCH 11, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 102 2/22/18 9:13 PM
103AHPBA 2018 ANNUAL MEETING
8:00am - 9:30am
Oral Presentations 10: Hepatobiliary II
Americana 3
Moderators: Patricio Polanco MD | University of Texas Southwestern Medical
Center; Henry Randall MD | SSM/Saint Louis University Hospital
8:00am - 8:12am
64. COMPLETION, AND NOT JUST INITIATION, OF INTENDED
ONCOLOGIC THERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL
AFTER PANCREATIC RESECTION FOR CANCER
Presenter: Danielle DePeralta MD | Moffitt Cancer Center
Invited Discussant: Eduardo Montalvo-Jave MD, PhD | Hospital General de
Mexico.
8:12am - 8:24am
65. CLINICAL CRITERIA FOR INTEGRATED MOLECULAR PATHOLOGY
IN IPMN: LESS IS MORE
Presenter: Rachel Simpson MD | Indiana University
Invited Discussant: Danny Yakoub MD, PhD | University of Miami
8:24am - 8:36am
66. NORMAL AND FIBROTIC LIVER PARENCHYMA RESPOND
DIFFERENTLY TO IRREVERSIBLE ELECTROPORATION ABLATION
Presenter: Tammy T. Chang MD, PhD | University of California, San Francisco
Invited Discussant: Tri Nguyen MD, PhD | Piedmont Atlanta Hospital
8:36am - 8:48am
67. A COMPARISON OF MICROWAVE THERMOSPHERE VERSUS
RADIOFREQUENCY THERMAL ABLATION IN THE TREATMENT OF
COLORECTAL LIVER METASTASES
Presenter: Kazunari Sasaki MD | Cleveland Clinic Foundation
Invited Discussant: Rob Martin MD, PhD | University of Louisville
8:48am - 9:00am
68. LOSS OF MUSCLE MASS DURING PREOPERATIVE CHEMOTHERAPY
PREDICTS WORSE RECURRENCE-FREE SURVIVIAL IN PATIENTS WITH
RESECTABLE COLORECTAL LIVER METASTASES
Presenter: Masayuki Okuno MD, PhD | The University of Texas MD
Anderson Cancer Center
Invited Discussant: Julie Hallet MD MSc | Sunnybrook Health Sciences
Centre, University of Toronto
SUNDAY, MARCH 11, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 103 2/22/18 9:13 PM
104 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
9:00am - 9:12am
69. ONCOLOGICAL BENEFIT OF COMPLETE METASTASECTOMY FOR
SIMULTANEOUS COLORECTAL LIVER AND LUNG METASTASES
Presenter: Masaru Matsumura MD | University of Tokyo
Invited Discussant: Hiromichi Ito MD | Cancer Institute Hospital, Japanese
Foundation for Cancer Research
9:12am - 9:28am
70. DISPARITIES IN HEPATOPANCREATOBILIARY OPERATIVE
EXPERIENCE AMONG GENERAL SURGERY RESIDENTS: A 27-YEAR
ANALYSIS OF ACGME CASE LOGS
Presenter: R. Cutler Quillin, III MD | Columbia University
Invited Discussant: C. Max Schmidt MD, PhD, MBA | Indiana University
School of Medicine
10:00am - 11:30am
Video Session Pancreas HPB
Americana 3
Moderators: Heber Ribeiro MD | AC Camargo Cancer Hospital; Roger Kim MD |
SIU School of Medicine
10:00am – 10:12am
V 15. LAPAROSCOPIC CENTRAL HEPATECTOMY FOR METASTATIC
COLORECTAL CANCER
Presenter: Ephraim Tang MD, MSc | Providence Cancer Center
10:12am - 10:24am
V 16. LAPAROSCOPIC LEFT EXTENDED HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA
Presenter: Katherine MacCallum MD | Montefiore Medical Center
10:24am - 10:36am
V 17. MULTIVISCERAL ROBOTIC LIVER RESECTIONS. FEASIBLE AND
SAFE
Presenter: Ioannis Konstantinidis MD | City of Hope National Cancer Center
10:36am - 10:48am
V 18. LAPAROSCOPIC RIGHT HEPATECTOMY FOLLOWING RIGHT
PORTAL VEIN EMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
Presenter: Katherine MacCallum MD | Montefiore Medical Center
SUNDAY, MARCH 11, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 104 2/22/18 9:13 PM
105AHPBA 2018 ANNUAL MEETING
10:48am - 11:00am
V 19. ROBOTIC CHOLEDOCODUODENOSTOMY
Presenter: Iswanto Sucandy MD | Florida Hospital Tampa
11:00am - 11:12am
V 20. ROBOT-ASSISTED INTRA/EXTRA/BILE DUCT EXPLORATION IN A
SICKLE CELL DISEASE PATIENT WITH BILIARY OBSTRUCTION
Presenter: Gregory Grimberg MD | Rutgers University
11:12am - 11:24am
V 21. LAPAROSCOPIC BEGER PROCEDURE
Presenter: Izrailov Roman MD | Moscow Clinical Scientific Center
10:00am - 11:30am
New Paradigms in Academic HPB Surgery
Americana 1
Moderator: Tara S. Kent MD | Beth Israel Deaconess Medical Center, Harvard
Medical School; Courtney L. Scaife MD | University of Utah
Health Services / Outcomes
Jennifer F. Tseng MD, MPH | Boston University School of Medicine
Multi-Institutional Databases
Timothy M. Pawlik MD, MPH, PhD | The Ohio State University Medical Center
Clinical Trials
William E. Fisher MD | Baylor College of Medicine
Innovation
Mariano Gimenez MD | University of Buenos Aires
International Outreach
T. Peter Kingham MD | Memorial Sloan Kettering Cancer Center
Administrative
Charles Wright Pinson MD, MBA | Vanderbilt University Medical Center
SUNDAY, MARCH 11, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 105 2/22/18 9:13 PM
106 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
10:00am - 11:30am
International Relations Committee | AHPBA Gone Global
Americana 2
Moderators: Alagappan Anand Annamalai MD | St. Vincent Medical Center;
Frans I. Serpa MD | Hospital Carlos Andrade Marin
Access to HPB Disease Care Worldwide
Gazi B. Zibari MD | Willis-Knighton Health System
Development of International AHPBA Chapters
Hoover Henriquez Cooper MD | Military Hospital Honduras
How to Improve HPB Education Through the Chapters
Oscar A. Guevara MD, MSc | Universidad Nacional de Colombia /
Instituto Nacional de Cancerologia
Challenges in the Interaction Between AHPBA and the Chapters
Javier C. Lendoire MD, PhD | Hospital Dr C Argeric
SUNDAY, MARCH 11, 2018
AG E N DA
AHPBA_2018_FinalProgram.indd 106 2/22/18 9:13 PM
107AHPBA 2018 ANNUAL MEETING
ePoster Displays | Monitor 5
P 2. A PREDICTIVE SCORING SYSTEM FOR INSUFFICIENT LIVER
HYPERTROPHY AFTER PREOPERATIVE PORTAL VEIN EMBOLIZATION
Presenter: Nobuyuki Watanabe MD | Shizuoka Cancer Center
P 5. SINGLE INCISION VERSUS THREE PORT LAPAROSCOPIC
CHOLECYSTECTOMY IN SYMPTOMATIC GALLSTONES: A
PROSPECTIVE RANDOMIZED STUDY
Presenter: Mohammed Omar MD | South Valley University, Qena Faculty of
Medicine
P 7. MALNUTRITION ASSOCIATED WITH POSTOPERATIVE
COMPLICATIONS IN PATIENTS UNDERGONE HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA
Presenter: Tzu Hao Huang MD | Chiayi Chang Gung Memorial Hospital
P 9. CIRRHOTIC CARDIOMYOPATHY AND DIASTOLIC DYSFUNCTION
IN LIVER TRANSPLANTATION
Presenter: Nyingi Kemmer MD | Tampa General Hospital
P 12. VIDEO CASE PRESENTATION: UTILITY OF ROBOTICS IN PARTIAL
HEPATECTOMY FOR ISOLATED LIVER METASTASIS
Presenter: Ashraf Elzanie MD | Saint Vincents Medical Center
P 13. VIDEO PRESENTATION: HAND-ASSISTED LAPAROSCOPIC
DISTAL PANCREATECTOMY AND SPLENECTOMY FOR DISCONNECTED
PANCREATIC DUCT SYNDROME
Presenter: Joseph Kim MD | Icahn School of Medicine at Mount Sinai
P 14. PANCREATICODUODENECTOMY WITH COMMON HEPATIC
ARTERY AND PORTAL VEIN RESECTION FOR LOCALLY ADVANCED
PANCREATIC CANCER
Presenter: Hiromichi Ito MD | Cancer Institution Hospital, Japanese
Foundation for Cancer Research
P 15. LAPAROSCOPIC RESECTION OF A COMPLEX SEGMENT III/IVB
LIVER CYST USING ULTRASONIC SURGICAL ASPIRATOR
Presenter: Eren Berber MD | Cleveland Clinic Foundation
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 107 2/22/18 9:13 PM
108 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
P 16. LAPAROSCOPIC RESECTION OF A SEGMENT VIII COLORECTAL
LIVER METASTASIS USING AN ULTRASONIC SURGICAL ASPIRATOR
Presenter: Eren Berber MD | Cleveland Clinic Foundation
P 17. RIGHT POSTERIOR SECTIONECTOMY WITH GLISSONIAN
APPROACH: ADVANTAGES OF HAND-ASSISTED LAPAROSCOPIC
TECHNIQUE
Presenter: Fabio Makdissi MD | University of Sao Paulo
P 19. PERI-OPERATIVE RISK FACTORS FOR POST OPERATIVE LIVER
FAILURE AFTER HEPATECTOMY: AN ACS-NSQIP ANALYSIS
Presenter: Travis Mason MD | Virginia Commonwealth University Medical
Center
P 21. ROBOTIC RESECTION OF EXTRAHEPATIC BILE DUCTS WITH LEFT
HEPATECTOMY AND CAUDATE LOBE RESECTION FOR BISMUTH TYPE
II PERI-HILAR CHOLANGIOCARCINOMA
Presenter: Sarah Corn MD | University of Kansas School of Medicine, Wichita
P 23. LAPAROSCOPIC COMPLETION CHOLECYSTECTOMY: AN AUDIT
FROM THE CARIBBEAN CHAPTER OF THE AHPBA
Presenter: Shamir Cawich MD | University of the West Indies
P 25. LAPAROSCOPIC CHOLEDOCHAL CYST EXCISION WITH
CHOLEDOCHODUODENOSTOMY USING NOVEL ARTICULATING
NEEDLE DRIVER
Presenter: Kellie Helin MD | West Virginia University Charleston
P 26. DUCT-PENETRATING METHOD FOR
PANCREATICOJEJUNOSTOMY USING A SUTURE-ASSISTANCE DEVICE:
OUTCOMES OF EARLY CLINICAL STUDY
Presenter: Tomio Ueno MD, PhD | Kawasaki Medical School
P 27. RESIDENT EXPERIENCE IN HEPATOPANCREATOBILIARY SURGERY
AT HIGH-VOLUME CENTERS: SHOULD IT COUNT?
Presenter: Manuel Castillo-Angeles MD, MPH | Beth Israel Deaconess
Medical Center
P 30. ROBOTIC APPROACH TO PANCREATIC RESECTION RE-VISITED
Presenter: Caitlin Takahashi MS | Florida State University, Sarasota Memorial
Hospital
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 108 2/22/18 9:13 PM
109AHPBA 2018 ANNUAL MEETING
P 32. OUTCOMES AFTER PANCREATICODUODENECTOMY IN PATIENTS
WITH SARCOPENIA AND/OR OBESITY
Presenter: William Lyman MD | Carolinas HealthCare System
P 33. FACTORS ASSOCIATED WITH RETURN TO OPERATING ROOM
FOLLOWING PANCREATIC RESECTION FOR MALIGNANCY
Presenter: Bradley Hall MD | University of Nebraska Medical Center
P 34. COMPARISON OF NEOADJUVANT GEMCITABINE VERSUS
5-FLUOROURACIL OR CAPECITABINE CHEMORADIATION FOR
BORDERLINE RESECTABLE PANCREATIC CANCER
Presenter: June Peng MD | Cleveland Clinic Foundation
P 36. LONG-TERM OUTCOMES OF PERIAMPULLARY
ADENOCARCINOMAS AFTER PANCREATICODUODENECTOMY – A
PERUVIAN MULTI-INSTITUTIONAL STUDY
Presenter: David Callacondo MD | Hospital Nacional Guillermo Almenara
Irigoyen
P 37. DOES SURGICAL VOLUME TRUMP DISPARITIES IN PREDICTING
OUTCOMES FOLLOWING HEPATOPANCREATICOBILIARY (HPB)
SURGERY?
Presenter: Britney Harris | West Virginia University
P 38. CLINICAL OUTCOMES AFTER MAJOR LIVER RESECTION IN A LOW
VOLUME CENTRE IN THE CARIBBEAN
Presenter: Shamir Cawich MD | University of the West Indies
P 39. LAPAROSCOPIC EXTENDED LYMPHADENECTOMY FOR
INCIDENTAL GALLBLADDER CANCER.
Presenter: Patricia Rebolledo MD | Hospital San Borja Arriaran
P 40. CRITICAL VIEW OF SAFETY IN CHOLECYSTECTOMY IS NOT A
WELL DISSEMINATED CONCEPT. A WEB BASED ANALYSIS
Presenter: Ismael Dominguez Rosado MD, MSc | Instituto Nacional de
Ciencias Médicas y Nutrición
P 41. SUBCUTANEOUS DRAINAGE TO PREVENT WOUND MORBIDITY
IN PATIENTS UNDERGOING PANCREATICODUODENECTOMIES: A
RETROSPECTIVE STUDY
Presenter: Emilio Alonso MD | Kaiser Permanente, Riverside Medical Center
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 109 2/22/18 9:13 PM
110 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
P 42. RACIAL DISPARITIES IN SURVIVAL AMONG PATIENTS WITH
RESECTED PANCREATIC ADENOCARCINOMA AND PANCREATIC
NEUROENDOCRINE TUMOR. MIAMI-BASED POPULATION STUDY.
Presenter: Basem Azab MD | University of Miami Miller School of Medicine
P 44. ARTERIO-VENOUS FISTULA AS A LATE COMPLICATION AFTER
DISTAL PANCREATECTOMY WITH EN BLOC SPLENIC VESSELS
LIGATION: MYTH OR REALITY?
Presenter: John Stauffer MD | Mayo Clinic, Florida
P 46. RESECTION VERSUS OBSERVATION OF SMALL
NONFUNCTIONING PANCREATIC NEUROENODCRINE TUMORS
Presenter: Nir Lubezky MD | Tel-Aviv Medical Center
P 47. THE ANTERIOR SECTOR VENOUS DRAINAGE USING SUPERFICIAL
FEMORAL VEIN GRAFT IN RIGHT LOBE LIVING DONOR LIVER
TRANSPLANTATION
Presenter: Shigeyuki Kawachi MD, PhD | Tokyo Medical University Hachioji
Medical Center
P 48. A SINGLE CENTER EXPERIENCE WITH DIAGNOSTIC
LAPAROSCOPY PRIOR TO PLANNED PANCREATIC RESECTION
Presenter: Jack Silva BS | UC Irvine
P 49. SURGICAL OUTCOMES IN PATIENTS WITH RESECTED
INSULINOMA
Presenter: Georgios Gemenetzis MD | Johns Hopkins University School of
Medicine
P 50. DOES SURGEON VOLUME MITIGATE PREDICTED RISK FOR
PATIENTS UNDERGOING PANCREATODUODENECTOMY?
Presenter: Zachary Stiles DO | University of Tennessee Health Science
Center
P 51. IS INTEGER-BASED RISK SCORE TO PREDICT IN-HOSPITAL
MORTALITY FOLLOWING PANCREATECTOMY RELIABLE?
Presenter: SANA BADAR MD | Louisiana State University Health Shreveport
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 110 2/22/18 9:13 PM
111AHPBA 2018 ANNUAL MEETING
ePoster Displays | Monitor 6
P 52. TRIGGERS FOR BLOOD TRANSFUSION DURING
PANCREATICODUODENECTOMY: ARE WE FOLLOWING
INSTITUTIONAL GUIDELINES?
Presenter: Daniel Rice BS | University of Cincinnati
P 53. PERIOPERATIVE OUTCOMES OF COMBINED SURGERY OF
PRIMARY COLORECTAL CANCER AND SYNCHRONOUS LIVER
METASTASES
Presenter: Jorge A Gajardo MD | Fundacion Arturo Lopez Perez
P 54. HEPATO-PANCREATO-BILIARY MALIGNANCIES IN PATIENTS
WITH CROHN’S DISEASE: A UNITED STATES POPULATION BASED
STUDY FROM NATIONAL INPATIENT SAMPLE DATABASE (1998-2010)
Presenter: Sachin Patil MD | South Central Regional Medical Cent
P 55. HEPATO-PANCREATO-BILIARY MALIGNANCIES IN PATIENTS
WITH CONNECTIVE TISSUE DISORDERS: A UNITED STATES
POPULATION BASED STUDY FROM NATIONAL INPATIENT SAMPLE
DATABASE (1998-2010)
Presenter: Apostolos Kandilis MD, PhD | Providence Park Hospital/Michigan
State University College of Human Medicine
P 56. IMPLEMENTATION AND EARLY OUTCOMES FOR A SURGEON-
DIRECTED HEPATIC ARTERIAL INFUSION PUMP PROGRAM FOR
COLORECTAL LIVER METASTASES
Presenter: Jeffery Chakedis MD | The Ohio State University
P 57. HEPATIC NEUROENDOCRINE TUMORS WITHOUT AN
IDENTIFIABLE EXTRAHEPATIC PRIMARY
Presenter: Lavanya Yohanathan MD | Mayo Clinic
P 58. TOTAL LAPAROSCOPIC PANCREATODUODENECTOMY WITH
EXTERNALIZED STENT IN A HIGH FISTULA RISK SCENARIO
Presenter: Ismael Dominguez Rosado MD, MSc | Instituto Nacional de
Ciencias Médicas y Nutrición
P 59. R0 RESECTION IMPROVES DISEASE-FREE SURVIVAL IN PATIENTS
WITH PANCREATIC NEUROENDOCRINE TUMORS INDEPENDENT OF
STAGE AND GRADE OF TUMOR
Presenter: Mazhar Khalil MD | Icahn School of Medicine at Mount Sinai
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 111 2/22/18 9:13 PM
112 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
P 60. NEO-ADJUVANT CHEOMORADIATION THERAPY FOR
PANCREATIC CANCER IS ASSOCIATED WITH ADVERSE OUTCOME
AFTER PANCREATICODUODECTOMY.
Presenter: Hassan Aziz MD | Banner University Medical Center
P 61. SARCOMATOUS TRANSFORMATION OF HEPATOCELLULAR
CARCINOMA FOLLOWING TREATMENT WITH Y-90
RADIOEMBOLIZATION
Presenter: Connor Wiles BS | Providence Portland Medical Center
P 62. ROBOTIC DUODENAL SURGERY IS A SAFE ALTERNATE TO
LAPAROSCOPIC AND OPEN RESECTION FOR BENIGN AND LOW
GRADE MALIGNANT CONDITIONS NOT AMENABLE TO ENDOSCOPIC
INTERVENTION
Presenter: Adeek Khan MD, MPH | Carolinas HealthCare System
P 63. SURVIVAL ANALYSIS IN PATIENTS WITH GALLBLADER CANCER
IN MEDELLIN-COLOMBIA
Presenter: jaime ramirez MD | IPS Universidad de Antioquia, Clinica Leon XIII
P 64. A MULTI-ORGAN STUDY USING COMPARING MICROWAVE
ABLATION 2450 MHZ SYSTEMS- EQUIVALENCE OR SUPERIORITY
Presenter: Megan Stevenson MD | University of Louisville School of Medicine
P 65. IS ENDOSCOPIC RETROGRADE CHOLANGIO PANCREATOGRAPHY
(ERCP) A RISK FACTOR FOR CONVERSION OF LAPAROSCOPIC
CHOLECYSTECTOMY? - EXPERIENCE OF A TERTIARY CARE
HEPATOBILIARY REFERRAL CENTRE
Presenter: Malith Nandasena MBBS, MD, MRCS | National Hospital of Sri
Lanka
P 66. CHOLEDOCHOPLASTY WITH GALLBLADDER WALL FREE FLAP:
A NOVEL TECHNIQUE FOR MIRIZZI’S SYNDROME AND BILE DUCT
INJURIES IN HIGH RISK PATIENTS
Presenter: Louis Chai MD | Drexel University College of Medicine
P 67. INDOCYANINE GREEN FLUORESCENCE COUNTERSTAINING FOR
ANATOMIC LAPAROSCOPIC PARTIAL SPLENECTOMY
Presenter: Takashi Mizuno MD, PhD | The University of Texas MD Anderson
Cancer Center
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 112 2/22/18 9:13 PM
113AHPBA 2018 ANNUAL MEETING
P 68. BMI AND PANCREATIC NECROSIS...DO OBESE PATIENTS DO
WORSE?
Presenter: Stephen Quigley MD | Indiana University
P 69. LONG TERM FOLLOW-UP RESULTS OF SURGICAL MANAGEMENT
OF CHRONIC PANCREATITIS
Presenter: Thiago Costa MD, PhD | Hospital das Clinicas of University of Sao
Paulo
P 71. DO SOLID ORGAN TRANSPLANT RECIPIENTS HAVE A HIGHER
RISK OF HEPATO-PANCREATO-BILIARY MALIGNANCIES? A UNITED
STATES POPULATION BASED STUDY FROM NATIONAL INPATIENT
SAMPLE DATABASE (1998-2010)
Presenter: Apostolos Kandilis MD, PhD | Providence Park Hospital/Michigan
State University College of Human Medicine
P 72. CONVENTIONAL PANCRETICOJEJUNOSTOMY VERSUS SUTURE-
LESS BINDING PANCREATICOGASTROSTOMY- A SINGLE INSTITUTION
SINGLE SURGEON COMPARITIVE STUDY
Presenter: Phani krishna Ravula MS, MRCS, MCh | Pace hospitals
P 73. SURGICAL RESULTS OF MAJOR AND MINOR LAPAROSCOPIC
HEPATECTOMIES
Presenter: Andres Troncoso MD | Pontificia Universidad Católica de Chile
P 74. FEASIBILITY OF LAPAROSCOPIC PARENCHYMAL SPARING
HEPATECTOMIES: A SYSTEMATIC REVIEW
Presenter: Jennifer Kalil MD | Rush University Medical Center
P 75. EFFECT OF INTENSIVE LIFESTYLE INTERVENTIONS ON LIVER
TRANSAMINASES
Presenter: Francisco Ramirez MD | Weimar Institute
P 76. PANCREATICODUODENECTOMY IN PATIENTS WITH ROUX-EN-Y
GASTRIC BYPASS: A MATCHED CASE-CONTROL STUDY
Presenter: John Stauffer MD | Mayo Clinic, Florida
P 77. PATTERNS OF RECURRENCE AND PERI-OPERATIVE PREDICTORS
OF LIVER METASTASIS AFTER PANCREATIC CANCER RESECTION
Presenter: Constantinos Zambirinis MR, MRes | Memorial Sloan Kettering
Cancer Center
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 113 2/22/18 9:13 PM
114 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
P 78. ORGAN PRESERVING PANCREATECTOMY FOR PANCREATIC
BENIGN OR LOW-GRADE MALIGNANT TUMOR: A REPORT OF 66
CASES IN A SINGLE INSTITUION
Presenter: weidong xiao MD, PhD | The First Affiliated Hospital of Nanchang
University
P 79. LAPAROSCOPIC LIVER RESECTION FOR METASTATIC MELANOMA
Presenter: Davit Aghayan MD | Oslo University Hospital
P 80. LIVER ABSCESS PATHOLOGY AND MANAGEMENT IN WESTERN
SYDNEY
Presenter: Yi Liang MBBS | Westmead Hospital
P 81. MAJOR PANCREAS RESECTION FOR ADENOCARCINOMA IN THE
ELDERLY PATIENTS; DOES AGE IMPACT THE OUTCOME?
Presenter: Alireza Hamidian Jahromi MD, MRCS | John C. McDonald
Regional Transplant Center
P 82. PANCREATICODUODENECTOMY WITH IRREVERSIBLE
ELECTROPORATION MARGIN ENHANCEMENT FOR BORDERLINE
RESECTABLE PANCREATIC CARCINOMA
Presenter: Amit Sastry MD | Carolinas HealthCare System
P 83. OUTCOMES OF PANCREATICODUODENECTOMY IN PATIENTS
WITH SUPERIOR MESENTERIC ARTERY CALCIFICATION
Presenter: Kelvin Wang BMBS, MRCS | St James’s University Hospital
P 85. PYOGENIC LIVER ABSCESS: EPIDEMIOLOGY, CLINICAL FEATURES
AND MANAGEMENT
Presenter: Helmut Alfredo Segovia Lohse MD | Hospital de Clínicas
P 86. CHOLECYSTECTOMY AFTER WALLED-OFF PANCREATIC
NECROSIS
Presenter: Joseph A Reza MD | Florida Hospital
P 87. STABILITY OF COUNTY RANKINGS IN LIVER TRANSPLANT
OUTCOMES
Presenter: Clifford Akateh MD | The Ohio State University and Nationwide
Children’s Hospital
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 114 2/22/18 9:13 PM
115AHPBA 2018 ANNUAL MEETING
P 88. PANCREATIC CYSTGASTROSTOMY: DEFINITIVE OR
TEMPORIZING PROCEDURE?
Presenter: Edward Cho MD | Methodist Richardson Medical Center
P 89. CONGENITAL COMMON BILE DUCT AGENESIS: AN EXTREMELY
RARE ANOMALY. TWO CASE REPORTS AND REVIEW OF LITERATURE.
Presenter: Louis Chai MD | Drexel University College of Medicine
ePoster Displays | Monitor 7
P 90. MAJOR HEPATECTOMY IN OCTOGENARIAN PATIENTS
Presenter: Andres Troncoso MD | Pontificia Universidad Católica de Chile
P 91. HEPATIC ADENOMAS: PHENOTYPIC EXPRESSION, CASE
DESCRIPTION AND LITERATURE REVIEW.
Presenter: Elaine Ataide PhD | University of Campinas
P 92. POSTOPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING
LAPAROSCOPIC CHOLECYSTECTOMY; VALIDATION OF THE RISK
CALCULATOR OF THE AMERICAN COLLEGE OF SURGEONS AT A
PRIVATE HOSPITAL IN MEXICO CITY.
Presenter: Victor José Visag-Castillo MD | Medica Sur Clinic Foundation
P 93. INCIDENCE OF SPLANCHNIC VEIN THROMBOSIS FOLLOWING
ABDOMINAL SURGERY, A SYSTEMATIC REVIEW AND META-
ANALYSIS.
Presenter: Minji Kim MD | McMaster University
P 94. WBC COUNT AS A SURROGATE OF SIRS IN THE EARLY
POST-OPERATIVE PERIOD. CAN IT PREDICT OUTCOMES AFTER
PANCREATICODUODENECTOMY?
Presenter: Spyridon Pagkratis MD | Methodist Richardson Medical Center
P 95. MODIFIED HEIDELBERG TECHNIQUE FOR PANCREATIC
ANASTOMOSIS
Presenter: Orlando Torres MD, PhD | Federal University of Maranhao
P 96. LAPAROSCOPIC RESECTION OF SEGMENT IVB/V COLORECTAL
LIVER METASTASIS USING A NEW MULTIFUNCTIONAL ARTICULATING
VESSEL SEALER
Presenter: Eren Berber MD | Cleveland Clinic Foundation
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 115 2/22/18 9:13 PM
116 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
P 97. BARBED SUTURE FOR PANCREATIC ANASTOMOSIS DURING
PANCREATICODUODENECTOMY DECREASES INCIDENCE OF
CLINICALLY SIGNIFICANT PANCREATIC FISTULA
Presenter: Andrew Guzowski MD | Cleveland Clinic, Akron General
P 99. MINIMALLY INVASIVE PANCREATECTOMY FOR
ADENOCARCINOMA; A SINGLE CENTER EXPERIENCE WITH 100
RESECTIONS
Presenter: Michael Passeri MD | Carolinas HealthCare System
P 101. THE PERSUIT OF SAFETY IN LAPAROSCOPIC HEPATECTOMY
Presenter: Naokazu Chiba MD, PhD | Tokyo Medical University Hachioji
Medical Center
P 102. PERCUTANEOUS CHOLECYSTOSTOMY FOR ACUTE CALCULOUS
CHOLECYSTITIS: OUTCOMES FROM A SINGLE CENTRE EXPERIENCE
Presenter: Francois Rouleau Fournier MD | CHU de Quebec - Laval University
P 103. TRANSVERSUS ABDOMINUS MUSCLE RELEASE WITH MESH
REINFORCEMENT IS SAFE AND EFFECTIVE FOR REPAIRING INCISIONAL
HERNIAS IN LIVER TRANSPLANT PATIENTS
Presenter: Dominic Sanford MD, MPHS | Washington University
P 104. PERCUTANEOUS TRANS-HEPATIC APPROACH TO ADDRESS
COMMON BILE DUCT STONE (CBDS) IN PATIENTS WHO HAD
LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS (LRYGB)
Presenter: Gazi B. Zibari MD | John C. McDonald Regional Transplant Center
P 105. ROBOTIC-ASSISTED COMPLETION CHOLECYSTECTOMY
FOLLOWING PREVIOUS SUBTOTAL CHOLECYSTECTOMY -- A CASE
SERIES
Presenter: William Lyman MD | Carolinas HealthCare System
P 106. POST-FELLOWSHIP COMMUNITY PRACTICE FACILITATES EARLY
ADOPTION OF ROBOTIC SURGERY AS ALGORITHM FOR APPROPRIATE
PATIENT SELECTION.
Presenter: Shanel Bhagwandin DO, MPH | Jupiter Medical Center
P 107. MANAGEMENT OF A DUODENOBRONCHIAL FISTULA AFTER
YTTRIUM 90 TRANSARTERIAL RADIOEMBOLIZATION IN A PATIENT
WITH RECURRENT HEPATOCELLULAR CARCINOMA
Presenter: Kliment Bozhilov MD | Johns Hopkins University School of
Medicine
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 116 2/22/18 9:13 PM
117AHPBA 2018 ANNUAL MEETING
P 108. HEPATOCELLULAR CARCINOMA INVADING BILE DUCTS
PRESENTING AS A KLATSKIN TUMOR
Presenter: Jorge Uribe MD | Drexel University College of Medicine
P 109. DUCT PENETRATING METHOD (DPM) FOR
PANCREATOJEJUNOSTOMY WITH AN INTERNAL STENT PLACEMENT
BY “PUSH & PULL TECHNIQUE”
Presenter: Mio Nakatani MD | Kawasaki Medical School
P 110. PANCREATIC PSEUDOCYST DILEMMA; CUMULATIVE MULTI-
CENTERS EXPERIENCE IN MANAGEMENT USING ENDOSCOPY,
LAPAROSCOPY, AND OPEN SURGERY
Presenter: Mohammed Omar MD | South Valley University, Qena Faculty of
Medicine
P 111. VIDEO-ASSISTED RETROPERITONEAL DEBRIDEMENT IN A
PATIENT WITH INFECTED NECROTIZING PANCREATITIS
Presenter: Helmut Alfredo Segovia Lohse MD | Hospital de Clínicas
P 112. HSP70, GLUTAMINE SYNTHETASE, GLIPICAN3, PD1, PDL1 AND
BETACATENIN: IMMUNOHISTOCHEMICAL STUDY IN PATIENTS
UNDERGOING HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA.
REVIEW OF RECURRENCE AND SURVIVAL.
Presenter: Simone Perales PhD | University of Campinas
P 113. MAJOR HEPATIC RESECTIONS IN A NEW HOSPITAL. HOW
AN EXPERIENCED SURGICAL GROUP CAN POSITIVELY AFFECT
OUTCOMES.
Presenter: Spyridon Pagkratis MD | Methodist Richardson Medical Center
P 114. BENEFITS OF AN EIGHT-TEEN DAY PROGRAM ON CHRONIC
HEPATITIS
Presenter: Francisco Ramirez MD | Weimar Institute
P 115. LAPAROSCOPIC COMMON BILE DUCT EXPLORATION USING
FLUOROSCOPY GUIDED STONE BASKET EXTRACTION IN THE
MANAGEMENT OF EXTRAHEPATIC BILE DUCT STONES: A JOSE R.
REYES MEMORIAL MEDICAL CENTER EXPERIENCE
Presenter: Alain Neil Ancheta MD | Jose R. Reyes Memorial Medical Center
P 117. PANCREATODUODENECTOMY: BRAZILIAN PRACTICE PATTERNS
Presenter: Orlando Torres MD, PhD | Federal University of Maranhao
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 117 2/22/18 9:13 PM
118 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
P 118. PANCREAS TRANSECTION WITH LINEAR STAPLER AND BIPOLAR
CAUTERY FORCEPS IN DISTAL PANCREATECTOMY
Presenter: Toshimasa Okada MD, PhD | Kawasaki Medical School
P 119. COMPLEX DISTAL PANCREATECTOMY PERFORMED AT A
COMMUNITY CANCER CENTER
Presenter: Benjamin Gough DO | Helen F Graham Cancer Center & Research
Institute
P 121. RADIO-EMBOLIZATION WITH YTTRIUM-90 MICROSPHERES
FOR UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA. WHO
GETS IT?
Presenter: Spyridon Pagkratis MD | Methodist Richardson Medical Center
P 122. ROLE OF FAT AND FIBROSIS IN POST-OPERATIVE PANCREATIC
FISTULA
Presenter: Suman Bhushan Koganti MD | Nizams institute of medical
sciences
P 124. THE FIRST US REPORT OF MRI EOVIST AS A BILIARY AGENT. 2
CASE REPORTS.
Presenter: Edward Cho MD | Methodist Richardson Medical Center
P 125. URGENCY SURGICAL TREATMENT FOR RUPTURED HEPATIC
ADENOMA: EXPERIENCE OF 23 YEARS.
Presenter: Elaine Ataide PhD | University of Campinas
P 126. THE ROLE OF BILIARY T-TUBES IN CONTEMPORARY
HEPATOBILIARY AND EMERGENCY SURGERY: HAS THEIR TIME
PASSED?
Presenter: Sushant Chaudhary MD | University of Calgary
P 127. CENTRAL HEPATECTOMY FOR RARE PURE SQUAMOUS CELL
CARCINOMA OF THE GALLBLADDER WITH LOCAL EXTENSION INTO
LIVER
Presenter: Jayne McCauley MD | Texas Tech University Health Sciences
Center
P 128. EPIDEMIOLOGY OF PANCREATIC SOLID PSEUDOPAPILLARY
NEOPLASMS IN A CARIBBEAN POPULATION
Presenter: Shamir Cawich MD | University of the West Indies
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 118 2/22/18 9:13 PM
119AHPBA 2018 ANNUAL MEETING
P 129. ACUTE LIVER FAILURE AS INITIAL PRESENTATION OF MULTIPLE
MYELOMA
Presenter: Amit Reddy MBBS | University of Mississippi Medical Center
P 130. HEPATIC ARTERY-PORTAL VEIN FISTULAS (APFS) FOLLOWING
A THORACO-ABDOMINAL STAB WOUND: CASE REPORT AND
LITERATURE REVIEW
Presenter: Amandeep Juneja MD | Staten Island University Hospital
ePoster Displays | Monitor 8
P 131. A CASE SERIES OF CENTRAL HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA - A USEFUL PARENCHYMA
PRESERVING TECHNIQUE TO PREVENT POST-HEPATECTOMY LIVER
FAILURE.
Presenter: Phani krishna Ravula MS, MRCS, MCh | Pace Hospital
P 132. DOES COMPLIANCE WITH AN ERAS PROTOCOL FOR
PANCREATICODUODENECTOMY LEAD TO A DIFFUSION EFFECT ON
COMPLIANCE FOR LEFT PANCREATECTOMY?
Presenter: Michael Passeri MD | Carolinas HealthCare System
P 133. MORBID THOUGHTS DECREASE ON INDIVIDUALS WITH
CONCUSSION HISTORY AFTER AN 8-WEEK EDUCATIONAL PROGRAM
Presenter: Francisco Ramirez MD | Nedley Clinic
P 135. PANCREATIC SURGERY IN OCTOGENARIAN PATIENTS
Presenter: Andres Troncoso MD | Pontificia Universidad Católica de Chile
P 136. THE PANCREAS AS A TARGET FOR METASTASES OF
ABDOMINAL TUMORS
Presenter: Gabriel E. Gondolesi MD | Hospital Universitario Fundación
Favaloro (HUFF)
P 137. CASE SERIES TYPE 2 AUTOIMMUNE PANCREATITIS (OR IDCP):
AN AUSTRALIAN CASE SERIES AND ANALYSIS OF DIAGNOSTIC
APPROACH
Presenter: Krishna Pattabathula MBBS | Wesley Hospital
P 138. MANAGEMENT OF PATIENTS WITH ADENOCARCINOMA
Presenter: Sean Willis MS | Holy Cross Hospital
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 119 2/22/18 9:13 PM
120 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA
P 139. FACTORS ASSOCIATED WITH BETTER SURVIVAL IN PATIENTS
UNDERGOING PANCREATICODUODENECTOMY FOR PANCREATIC
ADENOCARCINOMA
Presenter: Andres Troncoso MD | Pontificia Universidad Católica de Chile
P 141. SURGICAL IMPORTANCE OF DUCT OF LUSCHKA ON BILE DUCT
LEAK : EMPIRICAL REVIEW OF LITERATURE.
Presenter: Natalia Cortes MD | Hospital Universitaria San Ignacio
P 142. IGG4-RELATED CHOLECYSTITIS PRESENTING AS MIRIZZI
SYNDROME.
Presenter: Nuria Ortega MD | Vall D’Hebron Universitary Hospital
P 143. SUPERIOR INTRAOPERATIVE PERFORMANCE OF HARMONIC HD
1000I SHEARS FOR PANCREATICODUODENECTOMIES
Presenter: Edward Cho MD | Methodist Richardson Medical Center
P 144. D4 OPENS A DOOR: ENDOSCOPIC ULTRASOUND GUIDED
TRANSDUODENAL DRAINAGE OF PERIPANCREATIC ABSCESS:A CASE
REPORT AND LITERATURE REVIEW.
Presenter: Essa Aleassa MD, MSc | Cleveland Clinic Foundation
P 145. SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF
PANCREATIC CYSTIC NEOPLASMS IN A REFERRAL CENTRE ON HPB IN
COLOMBIA.
Presenter: Camilo Ramirez MD | Mederi Hospital
P 146. TRAUMATIC HEMOBILIA
Presenter: Timothy Sahawneh MD | East Tennessee State University
P 147. IRREVERSIBLE ELECTROPORATION FOR POST-
PANCREATICODUODENECTOMY LOCALLY RECURRENT PANCREATIC
ADENOCARCINOMA: A CASE PRESENTATION
Presenter: Kiara Tulla MD | University of Illinois at Chicago
P 148. PANCREATIC NEUROENDOCRINE TUMOR: A DIAGNOSTIC
CHALLENGE IN FINE NEEDLE ASPIRATION CYTOLOGY
Presenter: Amit Reddy MBBS | University of Mississippi Medical Center
P 149. HILAR BILE DUCT NEUROENDOCRINE TUMOR: AN INCIDENTAL
FINDING
Presenter: Amit Reddy MBBS | University of Mississippi Medical Center
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 120 2/22/18 9:13 PM
121AHPBA 2018 ANNUAL MEETING
P 150. DOUBLE CYSTIC MUCINOUS CYSTIC NEOPLASM AT THE BODY
AND THE TAIL OF THE PANCREAS.
Presenter: Natalia Lozano MD | Mederi Hospital
P 151. NEUROENDOCRIN TUMOR DE PANCREAS. PRESENTACION DE
AMPULOMAS CON HISTOLOGIA POCO FRECUENTE.
Presenter: Alejandro Fabian Rabellino MD | Hospital J. B. Iturraspe
P 152. EVERY OTHER DAY TREATMENT MAY REDUCE FATIGUE
IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH
STEREOTACTIC BODY RADIOTHERAPY
Presenter: Shaakir Hasan DO | Allegheny Health Network
P 153. IMPROVED PREDICTION OF HEPATIC FAILURE WITH THE
ALBUMIN-BILIRUBIN MODEL FOR HEPATOCELLULAR CARCINOMA
PATIENTS FOLLOWING STEREOTACTIC BODY RADIOTHERAPY WITH
AND WITHOUT TRANSPLANT
Presenter: Shaakir Hasan DO | Allegheny Health Network
HPB Fellowship Program ePosters
ePOSTER DISPLAYS BY MONITOR
AG E N DA
AHPBA_2018_FinalProgram.indd 121 2/22/18 9:13 PM